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Key	  points	  
•	  Loss	  of	  muscle	  mass	  and	  strength	  in	  the	  growing	  population	  of	  elderly	  people	  is	  a	  major	  health	  concern	  
for	  modern	   societies.	   This	   condition,	   termed	   sarcopenia,	   is	   a	  major	   cause	  of	   falls	   and	  of	   the	   subsequent	  
increase	  in	  morbidity	  and	  mortality	  
•	  Despite	  numerous	  studies	  on	  the	  impact	  of	  ageing	  on	  individual	  muscle	  fibres,	  the	  contribution	  of	  single	  
muscle	  fibres	  adaptations	  to	  ageing	  induced	  atrophy	  and	  functional	  impairment	  is	  still	  unsettled	  
•	  The	  level	  of	  physical	  function	  and	  disuse	  is	  often	  associated	  with	  aging	  
•	  We	  studied	  relatively	  healthy	  older	  adults	  in	  order	  to	  understand	  the	  effects	  of	  aging	  per	  se	  without	  the	  
confounding	  impact	  of	  impaired	  physical	  functional	  
•	  We	  found	  that	  in	  healthy	  ageing	  structural	  and	  functional	  alterations	  of	  muscle	  fibres	  occur.	  Protein	  post-­‐
translational	  modifications,	  oxidation	  and	  phosphorylation,	  contribute	  to	  such	  alterations	  more	  than	  loss	  of	  
myosin	  and	  other	  muscle	  proteins	  content	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Abstract	  	  
Contradictory	   results	  have	  been	   reported	  on	   the	   impact	  of	   ageing	  on	   structure	   and	   functions	  of	   skeletal	  
muscle	   fibres	   likely	   due	   to	   complex	   interplay	   between	   ageing	   and	   other	   phenomena	   such	   as	   disuse	   and	  
diseases.	  Here	  we	  recruited	  healthy,	  physically	  and	  socially	  active	  young	  (YO)	  and	  elderly	  (EL)	  men	  in	  order	  
to	   study	   aging	  per	   se	   without	   the	   confounding	   effects	   of	   impaired	   physical	   function.	   In	   vivo	   analyses	   of	  
quadriceps	   and	   in	   vitro	   analyses	   of	   vastus	   lateralis	  muscle	   biopsies	  were	   performed.	   In	   EL	   subjects,	   our	  
results	  show	  that:	  (i)	  quadriceps	  volume,	  maximum	  voluntary	  torque	  (MVC),	  and	  patellar	  tendon	  force	  (Ft)	  
were	  significantly	  lower;	  (ii)	  muscle	  fibres	  went	  through	  significant	  atrophy	  and	  impairment	  of	  specific	  force	  
(Po/CSA)	   and	  unloaded	   shortening	   velocity	   (Vo);	   (iii)	  myosin/actin	   ratio	   and	  myosin	   content	   in	   individual	  
muscle	   fibres	  were	  not	   altered;	   (iv)	  muscle	  proteome	  went	   through	  quantitative	   adaptations,	   namely	   an	  
up-­‐regulation	   of	   the	   content	   of	   several	   groups	   of	   proteins	   among	   which	   myofibrillar	   proteins	   and	  
antioxidant	   defence	   systems;	   (v)	   muscle	   proteome	   went	   through	   qualitative	   adaptations,	   namely	  
phosphorylation	  of	  several	  proteins,	  including	  Myosin	  Light	  Chain-­‐2	  slow	  and	  Troponin	  T	  and	  carbonylation	  
of	  Myosin	  Heavy	  Chains.	  The	  present	  results	  indicate	  that	  impairment	  of	  individual	  muscle	  fibres	  structure	  
and	  function	   is	  a	  major	  feature	  of	  ageing	  per	  se	  and	  that	  qualitative	  adaptations	  of	  muscle	  proteome	  are	  





ACTA,	  actin;	  ACTC,	  actin	  α	  cardiac;	  ALDOA,	  fructose-­‐biphosphate	  Aldolase	  A;	  BAP,	  brightness–area	  product;	  
CAH3,	   Carbonic	   anhydrase	   III;	   COX5A,	   Cytochrome	   c	   oxidase	   sub	   5A;	   CRYAB,	   α-­‐β-­‐crystallin;	   CSA,	   cross-­‐
sectional	   area;	   DLDH,	   Dihydrolipoyl	   dehydrogenase;	   EL,	   elderly;	   GSTM2,	   GAPDH,	   Glyceraldehyde	   3-­‐P	  
dehydrogenase;	  Glutathione-­‐S-­‐transferase	  Mu;	  GSTP1,	  Glutathione	  -­‐S-­‐transferase	  P;	  	  HBA,	  Hemoglobin	  sub	  
alpha;	  HBB,	  Hemoglobin	  sub	  beta;	  HSPB6,	  Heat	  Shock	  Protein	  beta	  6;	   LDHA,	   lactate	  dehydrogenase;	  MB,	  
myoglobin;	  MHC,	  myosin	  heavy	  chain;	  MLC,	  myosin	   light	  chain;	  P0,	   isometric	  force;	  P0/CSA,	  specific	  force;	  
PEBP1,	  Neuropolypeptide	  h3;	  PGM1,	  Phosphoglucomutase;	  PKM,	  pyruvate	  kinase;	  PRDX2,	  Peroxiredoxin	  2;	  
PRDX3,	   Peroxiredoxin3;	   PRDX6,	   Peroxiredoxin6;	   PSMA2,	   Proteasome	   α-­‐sub	   isoform	   2;	   	   ROS,	   reactive	  
oxygen	   species;	   SOD1,	   Cu/Zn	   Superoxide	   dismutase;	   TNNT1,	   troponin	   T	   slow;	   TNNT3,	   troponin	   T	   fast;	  
TPM1,	   tropomyosin	  alpha	   chain;	  UQCRC1,	  Ubiquinol-­‐cytochrome	  c	   reductase;	  UQCRC2,	  Cytochrome	  b-­‐c1	  
complex	  sub2;	  V0,	  unloaded	  shortening	  velocity;	  YO,	  young.	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Introduction	  
Loss	  of	  muscle	  mass	  and	  strength	  in	  the	  growing	  population	  of	  elderly	  people	  is	  a	  major	  health	  concern	  for	  
modern	   societies.	   This	   condition,	   generally	   termed	   sarcopenia	   (Evans	   &	   Campbell,	   1993;	   Fielding	   et	   al.,	  
2011),	  is	  a	  major	  cause	  of	  falls	  and	  of	  increased	  in	  morbidity	  and	  mortality	  in	  older	  people.	  
Multiple	   phenomena	   occurring	   at	   molecular,	   cellular	   and	   whole	   muscle	   levels	   can	   cause	   sarcopenia.	  
Interestingly,	   as	   a	   disproportionate	   loss	   of	   muscle	   force	   compared	   to	   muscle	   mass	   has	   been	   observed	  
(Servais	  et	  al.,	  2007)	  it	  has	  been	  understood	  that	  ageing	  can	  cause	  changes	  in	  muscle	  “quality”	  and	  not	  only	  
in	  muscle	  “quantity”.	  Several	  qualitative	  adaptations	  can	  affect,	  at	  variable	  extents,	  muscle	  function	  (Narici	  
&	  Maffulli,	  2010):	  increased	  fat	  and	  connective	  tissue	  content,	  variations	  in	  muscle	  architecture	  and	  tendon	  
compliance,	  neuromuscular	  junction	  integrity	  and	  excitation-­‐contraction	  coupling,	  changes	  in	  muscle	  fibres	  
type	   distribution	   and	   contractile	   properties.	   Moreover,	   analysis	   of	   muscle	   proteome	   has	   shown	   post-­‐
translational	  modifications	  (Baraibar	  et	  al.,	  2013;	  Li	  et	  al.,	  2015)	  and	  changes	  in	  content	  of	  muscle	  proteins	  
(Gelfi	  et	  al.,	  2006;	  Capitanio	  et	  al.,	  2009)	  independently	  from	  a	  change	  in	  total	  protein	  content.	  
Single	   muscle	   fibre	   structure	   and	   function	   are	   major	   determinants	   of	   muscle	   size	   and	   of	   the	   intrinsic	  
capacity	   to	  develop	   force	  of	  whole	  muscles	   in	  vivo.	  The	   impact	  of	  ageing	  on	   individual	  muscle	   fibres	  has	  
been	  extensively	  studied.	  Contradictory	  results	  have	  been	  reported	  and	  the	  contribution	  of	  single	  muscle	  
fibres	  adaptations	  to	  ageing	   induced	  atrophy	  and	  functional	   impairment	   is	  still	  unsettled.	  Consistent	  with	  
some	   earlier	  work	   (Larsson	   et	   al.,	   1997;	   D'Antona	   et	   al.,	   2003),	  muscle	   fibre	   atrophy	   and	   impairment	   in	  
muscle	   fibre	   specific	   force	  and	  unloaded	  shortening	  velocity	  have	  been	  considered	  major	   factors	  causing	  
sarcopenia.	  However,	  others	   reported	  no	  atrophy	  and	  no	   impairment	  of	   specific	   force	  and	  of	   shortening	  
velocity	   in	  elderly	   compared	   to	  young	  men	  and	  women	   (Trappe	   et	  al.,	  2003).	   It	  has	  been	  suggested	   that	  
discrepancies	  could	  be	  due	  to	  the	  different	  habitual	  physical	  activity	  background	  of	  the	  populations	  studied	  
(D'Antona	   et	  al.,	   2007).	   Indeed,	  exercise	   training	   can	   improve	  muscle	   fibre	   function	   (Trappe	   et	  al.,	   2000;	  
D'Antona	  et	  al.,	  2006),	  whereas	  disuse,	  which	  frequently	  occurs	  with	  ageing,	  is	  known	  to	  cause	  atrophy	  and	  
impairment	  of	  muscle	   fibre	   function	   (Brocca	  et	  al.,	  2015).	  Consistently,	  a	  study	  reported	  no	  difference	   in	  
cross	  sectional	  area	  (CSA),	  specific	  force	  and	  unloaded	  shortening	  velocity	  of	  individual	  muscle	  fibres	  from	  
young	   and	   elderly	   individuals	  matched	   for	   physical	   activity	   levels	   (Hvid	   et	   al.,	   2011).	   These	   observations	  
clearly	   indicate	   that	   habitual	   physical	   activity	   levels	   can	   modulate	   muscle	   fibre	   ageing,	   but	   one	   cannot	  
ignore	  the	  fundamental	  finding	  that	  muscle	  mass,	  strength	  and	  power	  decline	  with	  ageing	  even	  in	  master	  
athletes	  (Shanely	  et	  al.,	  2002;	  Shanely	  et	  al.,	  2004).	  
Not	  surprisingly,	  the	  causes	  of	  the	  loss	  of	  muscle	  fibre	  intrinsic	  function	  (force	  per	  unit	  area	  and	  unloaded	  
shortening	   velocity)	   in	   ageing	   are	   still	   unsettled.	   In	   sedentary	   and	   immobilized	   elderly	   subjects,	   lower	  
specific	  force	  of	  muscle	  fibres	  has	  been	  attributed	  to	  lower	  myosin	  concentration	  (D'Antona	  et	  al.,	  2003).	  
Post-­‐translational	  modifications	  have	  been	  shown	  to	  occur	  in	  ageing	  and	  potentially	  affect	  the	  capacity	  of	  
myosin	  to	  develop	  force	  and	  shortening	  (Li	  et	  al.,	  2015).	  Ageing	  has	  been	  suggested	  to	  cause	  alterations	  in	  
myosin	   structure	   and	   in	   acto-­‐myosin	   interaction	   possibly	   due	   to	   myosin	   oxidation	   (Prochniewicz	   et	   al.,	  
2007).	  Moreover,	   recent	  proteomic	  analyses	  have	  shown	  that	   in	  ageing,	  alterations	  can	  occur	  not	  only	   in	  
myosin	  content,	  but	  in	  the	  content	  of	  many	  myofibrillar	  proteins	  and	  of	  other	  functional	  groups	  of	  proteins	  
(e.g.	  metabolic	  enzymes	  and	  anti-­‐oxidant	  defence	  systems)	  (Gelfi	  et	  al.,	  2006;	  Capitanio	  et	  al.,	  2009).	  The	  
latter	   observations	   underlie	   the	   complexity	   of	   the	   adaptations	   in	   muscle	   protein	   pattern	   and	   suggest	  
factors	   in	   addition	   to	   myosin	   can	   impair	   muscle	   fibre	   function.	   However,	   it	   is	   difficult	   to	   unequivocally	  
attribute	   the	   above	   potential	   causes	   of	  muscle	   fibre	   function	   impairment	   to	   ageing,	   as	   reduced	   physical	  
activity	  has	   confounding	  effects.	   In	  healthy	   young	  adults,	   disuse	  has	  been	   shown	   to	   cause	   lower	   specific	  
force	   of	   muscle	   fibres	   based	   on	   lower	   myosin	   concentration	   (Borina	   et	   al.,	   2010;	   Brocca	   et	   al.,	   2015).	  
Moreover,	  protein	  oxidation	   (Dalla	  Libera	   et	  al.,	  2005)	  and	  myosin	   light	  chain	  phosphorylation	   (Maffei	   et	  
al.,	  2014)	  have	  been	  shown	  to	  occur	  in	  disuse	  and	  potentially	  affect	  myosin	  function	  (Coirault	  et	  al.,	  2007;	  
Maffei	   et	   al.,	   2014).	   Finally,	   disuse	   can	   cause	   profound	   alterations	   in	   muscle	   proteome,	   which	   partially	  
overlap	  with	  those	  observed	  in	  ageing	  (Brocca	  et	  al.,	  2012;	  Brocca	  et	  al.,	  2015;	  Hvid	  et	  al.,	  2016).	  	  
The	   aim	   of	   the	   present	   study	  was	   to	   examine	   the	   structure	   and	   function	   of	   single	  muscle	   fibres	   and	   to	  
identify	   underlying	   causes	   of	   functional	   impairments	   affecting	   fibres	   of	   older	   people.	   To	   reduce	   the	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confounding	  impact	  of	  disuse	  and	  diseases	  on	  ageing,	  we	  recruited	  relatively	  healthy,	  physically	  and	  socially	  
active	   older	   and	   younger	  men	   according	   to	   procedures	   previously	   described	   	   (McPhee	   et	   al.,	   2013a).	   As	  
impairment	  of	  muscle	   fibre	   function	   could	  depend	  on	  adaptations	  of	  muscle	  protein	   content	  we	   studied	  
myosin	   concentration	   and	  myosin/actin	   ratio	   in	   single	  muscle	   fibres	   and	   assessed	   adaptations	   in	   whole	  
protein	   pattern	   by	   proteome	   analysis	   (2-­‐DE)	   of	   bulk	   muscle	   samples.	   The	   potential	   role	   of	   qualitative	  
adaptations	  of	  proteins,	  namely	  oxidation	  and	  phosphorylation,	  was	  assessed	  by	  oxy-­‐blot	  of	  myosin	  heavy	  
chains	  and	  of	  muscle	  proteins	  and	  by	  phosphoproteome	  analysis	  of	  proteome	  2-­‐DE	  gels.	  
The	  present	  work	  suggests	  that	  structural	  and	  functional	  alterations	  of	  muscle	   fibres	  occur	  as	  part	  of	   the	  
normal	  ageing	  process.	  Post-­‐translational	  modifications,	  namely	  oxidation	  and	  phosphorylation,	  of	  several	  
muscle	  proteins	  contribute	  to	  such	  alterations	  more	  than	  loss	  of	  myosin	  and	  other	  muscle	  proteins	  content.	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Methods	  
Subjects	  and	  muscle	  biopsies	  
Ten	  elderly	  subjects	  (EL	  age	  70.9	  ±	  4.1	  years)	  and	  10	  young	  control	  subjects	  (YO	  age	  23.0	  ±	  2.2	  years)	  were	  
enrolled	  in	  the	  study.	  All	  subjects	  received	  and	  signed	  the	  informed	  consent.	  The	  study	  conformed	  to	  the	  
principles	   of	   the	   Declaration	   of	   Helsinki	   on	   human	   experimentation	   and	   was	   approved	   by	   the	   ethics	  
committee	   from	   Manchester	   Metropolitan	   University	   Both	   populations	   were	   physically	   active	   and	   free	  
from	  any	  musculoskeletal	   or	   chronic	   disease	   known	   to	   impact	   on	  physical	   activity	   levels.	   As	   reported	  by	  
McPhee	   et	   al.	   (McPhee	   et	   al.,	   2013a),	   physically	   active	   subjects	   were	   defined	   as	   “those	   involved	   in	  
moderate	   or	   vigorous	   activities	  where	   the	   intention	  was	   to	   improve	   health	   and	   fitness.	   Activity	   sessions	  
should	  work	  up	  a	  sweat	  and	  last	  around	  30	  min	  per	  session,	  for	  around	  3	  sessions	  per	  week	  and	  individuals	  
must	  have	  consistently	  maintained	  such	  activities	  for	  the	  majority	  of	  the	  year	  and	  for	  the	  past	  3	  years	  or	  
more”.	   The	   older	   participants	   completed	   the	   Voorrips	   physical	   activity	   questionnaire	   (score	   8.5	   ±	   0.9),	  
assessment	  of	  grip	  strength	  (37.4	  ±	  2.2	  kg)	  and	  walking	  speed	  during	  the	  6	  min	  walk	  test	  (1.64	  ±	  0.06	  m/s)	  	  
as	   previously	   described	   (McPhee	   et	   al.,	   2013b)	   to	   confirm	   they	   were	   not	   sedentary	   nor	   likely	   to	   be	  
sarcopenic	   or	   frail	   based	   on	   commonly	   used	   screening	   assessments	   (Cruz-­‐Jentoft	   et	   al.,	   2010).	   Those	  
involved	  in	  competitive	  exercise	  were	  excluded.	  
Muscle	  samples	  were	  taken	  by	  needle	  biopsy	  under	  local	  anesthesia	  from	  the	  vastus	  lateralis	  muscle	  using	  
a	  procedure	  previously	  described	  (Bergstrom,	  1979;	  Bottinelli	  et	  al.,	  1996).	  Muscle	  samples	  were	  divided	  in	  
several	  portions:	  two	  were	   immediately	  frozen	   in	   liquid	  nitrogen	  and	  used	  for	  myosin	  heavy	  chain	  (MHC)	  
and	   myosin	   light	   chain	   (MLC)	   isoform	   distribution	   analysis,	   myosin/actin	   ratio	   analysis,	   MLC	  
phosphorylation	  analysis,	  proteomic	  analysis,	  phosphoprotein	  analysis	  and	  protein	  oxidation	  analysis.	  One	  
piece	   of	   biopsy	  was	   divided	   in	   smaller	   bundles,	   stored	   at	   -­‐20°C	   in	   skinning	   solution	   (150	  mm	  potassium	  
propionate,	   5	   mm	   KH2PO4,	   5	   mm	   magnesium	   acetate,	   3	   mm	   Na2ATP,	   5	   mm	   EGTA,	   pCa	   9.0)	   plus	   50%	  
glycerol	  and	  used	  to	  determine	  the	  cross-­‐section	  area	  (CSA),	  force	  (Po),	  maximum	  shortening	  velocity	  (Vo)	  
and	  myosin	  concentration	  of	  dissected	  single	  fibers.	  	  
In	  vivo	  analyses	  
Magnetic	  resonance	  imaging	  
The	  right	  knee	  and	  thigh	  was	  imaged	  using	  a	  0.25-­‐T	  MRI	  scanner	  (G-­‐scan,	  Esaote	  Biomedica,	  Genoa,	  Italy)	  
as	   participants	   lay	   supine	   with	   both	   legs	   fully	   extended	   (Shoepe	   et	   al.,	   2003).	   Transverse-­‐plane	   cross	  
sections	  were	  collected	  from	  the	  tibial	  tubercle	  of	  the	  knee	  joint	  through	  to	  the	  anterior-­‐inferior	  iliac	  spine	  
of	   the	   hip	   using	   Turbo-­‐3D	   T-­‐1	  weighted	   protocols	   and	   2.8	  mm	   thick	   slices	  with	   0	  mm	  distance	   between	  
slices.	   Using	   off-­‐line	   computer	   software	   (OiyriX,	   Pixmeo,	   Switzerland),	   anatomical	   cross-­‐sectional	   area	   of	  
the	  quadriceps	  muscles	  was	  measured	  at	  25mm	   intervals	   from	  distal	   to	  proximal	  ends	  of	   the	  quadriceps	  
and	  integrated	  to	  estimate	  quadriceps	  muscle	  volume	  (Qvol)	  (Shoepe	  et	  al.,	  2003).	  A	  sagittal-­‐plane	  scan	  of	  
the	  entire	  knee	  joint	  was	  also	  collected	  using	  the	  same	  scanning	  parameters.	  From	  the	  centre	   image,	  the	  
mid-­‐point	   between	   the	   surface	   of	   the	   femoral	   condyles	   and	   the	   tibial	   plateau	   was	   located	   and	   a	  
measurement	  taken	  as	  a	  straight	  line	  from	  this	  point	  to	  intercept	  perpendicular	  with	  the	  mid-­‐point	  of	  the	  
patella	   tendon	   to	   estimate	   patella	   tendon	  moment	   arm	   length	   (Shoepe	   et	   al.,	   2003).	   The	  moment	   arm	  
values	  were	  multiplied	  by	  0.99	  to	  account	  for	  the	  fact	  that	  the	  images	  were	  collected	  with	  a	  fully	  extended	  
knee	  joint,	  but	  isometric	  torque	  was	  measured	  at	  90°	  knee	  flexion	  (Song	  et	  al.,	  2009).	  	  
Patella	  tendon	  force	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Knee	   extension	   maximal	   voluntary	   contraction	   isometric	   torque	   (MVC)	   was	   assessed	   at	   90°	   knee	   angle	  
(where	  full	  knee	  extension	  is	  0°)	  with	  the	  back	  supported	  at	  85°	  (where	  lying	  supine	  is	  0°)	  and	  a	  strap	  firmly	  
securing	  the	  hips	  to	  the	  dynamometer	  chair	  and	  the	  ankle	  to	  the	  lever	  arm	  2	  cm	  above	  the	  ankle	  malleolus.	  
A	   familiarisation	   and	  warm-­‐up	   included	   3	   -­‐	   5	   contractions	   at	   around	   50%	  of	  maximal	   effort	   each	   lasting	  
around	   3	   s	   and	   another	   two	   further	   contractions	   at	   around	   80%	   maximal	   effort.	   After	   a	   short	   rest,	  
participants	  performed	  a	  maximal	  effort	  by	  increasing	  torque	  voluntarily	  and	  sustaining	  the	  maximal	  effort	  
for	  around	  3	  s.	  Visual	  feedback	  was	  available	  to	  the	  participants	  and	  verbal	  encouragement	  was	  provided.	  
The	  highest	  of	  three	  maximal	  efforts	  was	  taken	  as	  MVC.	  
The	  patella	  tendon	  force	  (Ft)	  was	  estimated	  by	  dividing	  the	  MVC	  by	  the	  patella	  tendon	  moment	  arm	  length.	  
The	  quadriceps	  in	  vivo	  specific	  force	  was	  estimated	  by	  dividing	  the	  Ft	  by	  quadriceps	  muscle	  volume.	  	  
	  
Single	  fiber	  analysis	  
Cross-­‐sectional	  area	  (CSA),	  force	  and	  maximum	  shortening	  velocity	  of	  single	  muscle	  fibres	  were	  analyzed	  as	  
previously	  described	  in	  detail	  (Bottinelli	  et	  al.	  1994,	  1996).	  Briefly,	  segments	  of	  single	  fibres	  were	  manually	  
isolated	   from	  muscle	   bundles	  with	   the	   help	   of	   a	   stereomicroscope	   at	   20-­‐40X	  magnifications	   in	   a	  muscle	  
chamber	  containing	  skinning	  solution	  (K-­‐p	  150	  mM,	  KH2PO4	  5mM,	  MgAc	  5	  mM,	  DTT	  1	  mM,	  EGTA	  5	  mM,	  
Na2-­‐ATP	  3	  mM,	  pH	  7,	  Leupeptine	  Hydrochloride	  20µg/ml,	  E64	  10	  µM).	  The	  fibres	  were	  immersed	  for	  1	  h	  in	  
skinning	   solution	  containing	  0.1%	  Triton	  X-­‐100	  and	  afterward	   returned	   to	   the	  previous	   skinning	   solution.	  
Each	   fibre	  was	  mounted	  between	   two	  hooks	  on	  a	   stage	  of	   an	   inverted	  microscope;	  CSA	  and	   length	   (2-­‐3	  
mm)	  were	  measured	  in	  order	  to	  calculate	  the	  volume	  assuming	  an	  elliptical	  shape	  of	  the	  cross	  section.	  The	  
width	  and	  the	  depth	  of	  the	  fibres	  were	  measured	  with	  an	  inverted	  microscope	  at	  320x	  magnification	  on	  10	  
different	  positions	  along	  the	  fiber.	  Using	  the	  mean	  values	  of	  width	  and	  the	  depth,	  CSA	  was	  determined.	  The	  
volume	  was	  then	  calculated	  by	  multiplying	  CSA	  and	  length	  thus	  obtained.	  
Isometric	   force	   (P0)	   and	   unloaded	   shortening	   velocity	   (V0)	   were	   measured	   by	   the	   slack	   test	   technique.	  
Briefly,	  each	   fibre	  was	  placed	   in	  activation	  solution:	   	  100	  mm	  KCl,	  20	  mm	  imidazole,	  5	  mm	  MgCl2,	  5	  mm	  
Na2ATP,	  0.5	  mm	  EGTA,	  25	  mm	  creatine	  phosphate,	  300	  U	  ml−1	  creatine	  kinase,	  pCa	  8.0.	  Experiments	  were	  
performed	  at	  12°C,	  in	  conditions	  of	  maximal	  activation	  (pCa	  4.5)	  and	  at	  optimal	  sarcomere	  length	  (2.5	  µm)	  
for	   force	   developing	   (Bottinelli	   &	   Reggiani,	   2000;	   D'Antona	   et	   al.,	   2003).	   For	   each	   of	   the	   10	   elderly	   and	  
young	  subjects,	  at	  least	  10	  single	  muscle	  fibres	  were	  dissected.	  At	  the	  end	  of	  mechanical	  experiment,	  fibres	  
were	   characterized	   on	   the	   basis	   of	   MHC	   isoform	   composition.	   Assuming	   that	   there	   are	   no	   variations	  
between	   subjects,	   a	   general	   average	   of	   all	   single	   muscle	   fibre	   value	   was	   made	   for	   each	   functional	  
parameters	  analysed.	  	  
	  
Myosin	  concentration	  analysis	  
Myosin	  concentration	  analysis	  was	  performed	  using	  an	  approach	  previously	  described	   in	  detail	   (D'Antona	  
et	  al.,	  2003;	  Borina	   et	  al.,	  2010)	  with	  some	  modifications.	  After	  mechanical	  experiments,	   the	   fibres	  were	  
placed	   in	   30	  µl	   of	   standard	   buffer	   (Soriano	   et	   al.,	   2006)	   at	   4	  °C	   for	   18	   h	   to	   complete	  myosin	   extraction.	  
Subsequently,	   10	   µl	   and	   20	   µl	   of	   buffer	   in	  which	   the	   fibre	   segment	  was	   dissolved,	  were	   loaded	   on	   12%	  
linear	  polyacrylamide	  gel,	  run	  at	  16	  mA	  for	  4	  h	  at	  4	  °C	  and	  stained	  with	  Colloidal	  Coomassie	  (Gelcode	  Blue	  
Stain	   Reagent	   –	   Pierce).	   In	   the	   same	   gel,	   a	   known	   amount	   of	  myosin	   standard	  were	   loaded	   in	   order	   to	  
determine	  a	  standard	  curve.	  
The	  brightness–area	  product	  (BAP)	  of	  the	  myosin	  bands	  was	  determined	  on	  gels	  imaged	  using	  the	  software	  
Adobe	  Photoshop	  CS3	  (Adobe).	  BAP	  correspond	  to	  product	  of	  the	  number	  of	  pixels	  of	  the	  whole	  MHC	  band	  
for	   the	   mean	   intensity	   level	   of	   the	   pixels.	   The	   myosin	   concentration	   standard	   curve	   was	   built	   plotting	  
together	   BAP	   values	   from	   myosin	   standard	   and	   known	   amount	   of	   myosin	   loaded.	   Finally,	   BAP	   values	  
evaluated	  for	  each	  single	  fiber	  were	  inserted	  in	  the	  standard	  curve	  obtaining	  their	  myosin	  concentration.	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Myosin/actin	  ratio	  analysis	  
Muscle	   biopsies,	   previously	   stored	   at	   −80°C,	   were	   pulverized	   with	   liquid	   nitrogen	   and	   immediately	  
suspended	  in	  lysis	  buffer	  (50	  mM	  Tris-­‐HCl	  pH	  7.6,	  250	  mM	  NaCl,	  5mM	  EDTA,	  1.5%	  v/v	  β-­‐mercaptoethanol	  
and	   2%	   inhibitor-­‐proteases	   cocktail	   by	   Sygma-­‐Aldrich).	   A	   protein	   assay	   kit	   (RC	   DC	   Biorad)	   was	   used	   to	  
determine	  protein	  concentration.	  For	  each	  subject	  10	  µg	  of	  sample	  were	  loaded	  into	  a	  precast	  gradient	  gel	  
(AnykD,	  Biorad).	  The	  gel	  run	  1	  h	  at	  room	  temperature	  at	  100	  V	  and	  then	  it	  was	  stained	  with	  Coomassie	  Blue	  
and	   acquired	  with	   a	   high	   resolution	   scanner	   (EPSON	   expression	   1680	   Pro).	   The	   brightness–area	   product	  
(BAP)	  of	  myosin	  and	  actin	  bands	  of	  each	  sample	  was	  measured	  using	  the	  software	  Adobe	  Photoshop	  CS3	  
(Adobe)	  and	  the	  myosin-­‐actin	  ratio	  was	  then	  calculated.	  
Myosin	  heavy	  chain	  isoform	  distribution	  analysis	  
Separation	   and	   identification	  of	  myosin	  heavy	   chain	   (MHC)	   isoforms	   in	   single	   fibres	   and	   in	  whole	  biopsy	  
was	   performed	   as	   previously	   described	   (Bottinelli	   et	   al.,	   1996;	   D'Antona	   et	   al.,	   2003;	   Pellegrino	   et	   al.,	  
2011a).	  Single	  muscle	  fibre	  segments	  used	  for	  mechanical	  experiments	  were	  dissolved	  in	  Laemmli	  solution	  
(Soriano	  et	  al.,	  2006)	  and	  loaded	  on	  6%	  SDS-­‐PAGE	  polyacrylamide	  gels.	  Electrophoresis	  was	  run	  overnight	  
at	  100	  V;	  following	  silver	  stain,	  three	  bands	  were	  separated	  in	  the	  region	  of	  MHC	  isoforms.	  	  
MHC	   isoform	   composition	  was	   assessed	   in	   the	  whole	   biopsy.	   In	   this	   case,	   frozen	   portion	   of	   biopsy	  was	  
pulverized	  in	  a	  steel	  mortar	  with	  liquid	  nitrogen	  to	  obtain	  a	  powder	  that	  was	  immediately	  resuspended	  in	  a	  
in	  Laemmli	  solution	  (Soriano	  et	  al.,	  2006).	  The	  samples	  were	  incubated	  in	  ice	  for	  20	  min	  and	  finally	  spun	  at	  
18000	  g	  for	  30	  min.	  Protein	  concentration	  in	  the	  dissolved	  samples	  was	  determined	  with	  a	  protein	  assay	  kit	  
(RC	  DC	  Biorad).	  About	  10	  µg	  of	  proteins	  for	  each	  sample	  were	  loaded	  on	  6%	  SDS-­‐PAGE	  polyacrylamide	  gels	  
and	  the	  electrophoresis	  was	  run	  overnight	  at	  100	  V;	  following	  Coomassie	  stain,	  three	  bands	  corresponding	  
to	  MHC	   isoforms	  were	   separated	   and	   their	   densitometric	   analysis	   was	   performed	   to	   assess	   the	   relative	  
proportion	   of	   MHC	   isoforms	   (MHC-­‐1,	   MHC-­‐2A	   and	   MHC-­‐2X)	   in	   the	   samples	   (Pellegrino	   et	   al.,	   2003;	  
Pellegrino	  et	  al.,	  2011a).	  
Proteome	  analysis	  (2-­‐DE)	  
Sample	  preparation.	  
Muscle	   samples,	  were	  prepared	  with	   the	   same	  procedures	  used	  previously	   (Brocca	  et	  al.,	   2010).	   	   Frozen	  
portion	   of	   biopsy	   was	   pulverized	   in	   a	   steel	   mortar	   with	   liquid	   nitrogen	   to	   obtain	   a	   powder	   that	   was	  
immediately	  resuspended	  in	  a	  lysis	  buffer	  (8	  M	  urea,	  2	  M	  thiourea,	  4%	  Chaps,	  65mM	  DTT	  and	  40	  mM	  Tris	  
base).	   The	   samples	  were	  vortexed,	   frozen	  with	   liquid	  nitrogen,	   thawed	  at	   room	   temperature	   four	   times,	  
incubated	  with	  DNase	  and	  RNase	  for	  45min	  at	  4◦C	  to	  separate	  proteins	  from	  nucleic	  acids	  and	  finally	  spun	  
at	  18000	  g	  for	  30	  min.	  Protein	  concentration	  in	  the	  dissolved	  samples	  was	  determined	  with	  a	  protein	  assay	  
kit	   (2D	  quant	   Kit,	  GE	  Healthcare).	   A	   sample	  mix	  was	   obtained	   for	   each	   experimental	   group	   (YO	   and	   EL).	  
Sample	   mix	   contained	   an	   equal	   protein	   quantity	   taken	   from	   each	   muscle	   sample	   of	   young	   and	   elderly	  
subjects.	  
Two-­‐dimensional	  electrophoresis.	  
First	   dimension,	   isoelectrofocusing,	   was	   carried	   out	   using	   IPGphor	   system	   (Ettan	   IPGphor	   isoelectric	  
Focusing	  Sistem	  -­‐	  GE	  Healthcare).	  150	  μg	  of	  proteins	  were	  loaded	  on	  IPG	  gel	  strips,	  pH	  3-­‐11	  NL	  (non	  linear)	  
13	  cm,	  that	  were	  rehydrated	  for	  14h,	  at	  30	  Volt	  and	  at	  20°C,	  in	  250	  μl	  of	  reswelling	  buffer	  (8	  M	  urea,	  2	  M	  
thiourea,	  2%	  (w/v)	  CHAPS,	  0.1%	  (v/v)	  tergitol	  NP7	  (Sigma),	  65	  mM	  DTT,	  0.5%	  (v/v)	  pharmalyte	  3-­‐11NL	  (GE	  
Healthcare)).	  Strips	  were	  focused	  at	  20000	  Vhr,	  at	  constant	  temperature	  of	  20°C	  and	  limiting	  the	  current	  to	  
50	  μA	  per	   IPG	  gel	   strip.	  After	   isoelectrofocusing	   the	   strips	  were	   stored	  at	   -­‐80°C	  until	   use	  or	   equilibrated	  
immediately	  for	  10-­‐12	  min	  in	  5	  ml	  of	  equilibration	  buffer	  (50	  mM	  Tris	  pH	  6.8,	  6	  M	  urea,	  30%	  (v/v)	  glycerol,	  
2%	  (w/v)	  SDS,	  3%	  (w/v)	  iodoacetamide).	  Then,	  the	  immobiline	  IPG	  gel	  strips	  were	  applied	  to	  15%	  T,	  2.5%	  C	  
polyacrylamide	   gels	   without	   a	   stacking	   gel.	   The	   separation	   was	   performed	   at	   80	   V	   for	   17h	   at	   room	  
temperature.	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2D	   gels	   were	   fixed	   for	   2h	   in	   fixing	   solution	   (ethanol	   40%	   (v/v)	   acetic	   acid	   10%	   (v/v)),	   stained	   with	  
fluorescent	  staining	  (FlamingoTM	  Fluorescent	  Gel	  Stain	  by	  BIO-­‐RAD)	  for	  3h	  and	  destained	  with	  0.1%	  (w/v)	  
Tween	  20	  solution	  for	  10	  minutes.	  	  
Triplicate	   gels	   of	   each	   sample	   group	   were	   obtained,	   visualised	   using	   a	   Typhoon	   laser	   scanner	   (GE	  
Healthcare)	  and	  analysed	  with	  Platinum	  Software	  (GE	  Healthcare).	  For	  the	  analysis,	  we	  have	  chosen	  one	  gel	  
as	  a	  master	  gel	  to	  perform	  automatic	  spots	  matching.	  Only	  the	  spots	  present	  in	  all	  gels	  were	  considered	  for	  
analysis.	  The	  variation	  of	  the	  expression	  of	  each	  spot	  was	  evaluated	  by	  calculating	  the	  ratio	  between	  the	  
average	  volume	  of	  a	  given	  protein	  expressed	  in	  the	  EL	  group	  and	  the	  average	  volume	  of	  the	  same	  spot	  in	  
the	   YO	   group.	   In	   the	   x-­‐axis	   of	   the	   histogram,	   positive	   numbers	   indicate	   upregulation	   whereas	   negative	  
numbers	   downregulation	   of	   the	   spots.	   2D	   gels	   were	   used	   to	   find	   the	   protein	   differences.	   All	   spots	  
statistically	   changed	   (P	   <	   0.05)	   were	   considered	   and	   then	   analysed	   by	   Mass	   Spectrometry	   in	   order	   to	  
identify	  the	  corresponding	  protein.	  
Phosphoproteome	  analysis	  
For	  this	  analysis	  the	  same	  samples	  prepared	  for	  proteome	  analysis	  were	  used.	  Before	  electrophoretic	  run,	  
the	   samples	   were	   delipidated	   and	   desalted	   in	   order	   to	   obtain	   an	   adequate	   separation	   and	   subsequent	  
staining	   specific	   for	   phosphoproteins.	   600	   µl	   of	  methanol,	   150	   µl	   of	   chloroform	   and	   450	   µl	   of	   ultrapure	  
water	  were	  added	  at	  150	  µl	  of	  samples	  (300	  µg	  of	  proteins)	  and	  the	  samples	  were	  centrifuged	  at	  18000	  g	  
for	  5	  minutes.	  After	  discarding	   the	  upper	  phases,	  450	  µl	  of	  methanol	  were	  added	  and	   the	  samples	  were	  
spun	   at	   18000	   g	   for	   5	  minutes.	   Finally,	   the	   pellet	  was	   resuspended	   in	   reswelling	   buffer	   (8	  M	   urea,	   2	  M	  
thiourea,	  2%	  (w/v)	  CHAPS,	  0.1%	  (v/v)	  tergitol	  NP7	  (Sigma),	  65	  mM	  DTT,	  0.5%	  (v/v)	  pharmalyte	  3-­‐11NL	  (GE	  
Healthcare))	  and	  2D	  proteome	  analysis	  was	  carried	  out	  with	  the	  same	  conditions	  as	  previously	  described.	  
After	  electrophoresis	  run,	  gels	  were	  fixed	  (methanol	  50%	  (v/v)	  acetic	  acid	  10%	  (v/v))	  overnight,	  stained	  with	  
Pro-­‐Q®	  Diamond	  phosphoprotein	   gel	   stain	   (Thermo	   fisher)	   for	   90	  minutes	   and	  destained	   for	   30	  minutes	  
with	   destain	   solution	   (20%	  acetonitrile,	   50	  mM	   sodium	  acetate,	   pH	   4.0).	  Gels	  were	   finally	  washed	   twice	  
with	  ultrapure	  water	  and	  visualised	  using	  a	  Typhoon	  laser	  scanner	  (ex	  555	  nm	  /	  em	  580	  nm).	  
Gels	  were	  subsequently	  stained	  with	  SYPRO	  Ruby	  dye	  (Termo	  fisher)	  in	  order	  to	  stain	  all	  protein	  spots.	  Gels	  
were	  stained	  on	  an	  orbital	  shaker	  overnight,	  then	  placed	  in	  wash	  solution	  (10%	  methanol	  (v/v),	  7%	  acetic	  
(v/v))	  for	  30	  minutes	  and	  finally	  rinse	  twice	  in	  ultrapure	  water.	  Gels	  were	  again	  visualised	  using	  a	  Typhoon	  
laser	  scanner	  (ex	  450	  nm	  /	  em	  610	  nm).	  	  
The	  ratio	  of	  Pro-­‐Q®	  Diamond	  dye	  to	  SYPRO®	  Ruby	  dye	  signal	  intensities	  were	  calculated	  for	  each	  spot	  and	  
this	  provided	  a	  measure	  of	  the	  phosphorylation	  level	  normalized	  to	  the	  total	  amount	  of	  protein.	  
Protein	  Identification	  by	  Mass	  Spectrometry	  (MS)	  and	  Database	  Searching.	  
In	   order	   to	   identify	   the	   protein	   spots	   that	   were	   found	   to	   be	   significantly	   different	   between	   EL	   and	   YO	  
groups,	  mass	  spectrometry	  was	  performed.	  Briefly,	  2D	  gels	  were	  loaded	  with	  300	  µg	  of	  proteins	  per	  strip	  
and	  the	  electrophoretic	  run	  was	  carried	  out	  with	  the	  same	  conditions	  described	  above.	  After	  staining	  with	  
Colloidal	  Coomassie,	  spots	  of	  interest	  were	  excised	  from	  the	  gel;	  spots	  were	  first	  destained	  two	  times	  with	  
a	  mixture	  of	  100	  mM	  ammonium	  bicarbonate	  (ABC)	  and	  50%	  (v/v)	  acetonitrile	  (ACN)	  for	  45	  min	  at	  22°C	  and	  
then	  dried	  using	  100%	  ACN	  for	  15	  min.	  Protein	  spots	  were	   then	  reduced	  with	  25	  mM	  ABC	  containing	  10	  
mM	  DTT	  for	  1	  h	  at	  60°C	  and	  then	  alkylated	  with	  55	  mM	  iodoacetamide	  in	  25	  mM	  ABC	  for	  30	  min	  in	  the	  dark	  
at	  22°C.	  Gels	  pieces	  were	  washed	  twice	  with	  25	  mM	  ABC	  and	  finally	  shrunk	  two	  times	  with	  100%	  ACN	  for	  
15	  min	   and	   dried	   using	   100%	  ACN	   for	   10	  min.	   After	   the	   dehydratation	   for	   1	   h	   at	   60°C,	   gel	   pieces	  were	  
incubated	  with	  13	  μl	  of	  sequencing	  grade	  modified	  trypsin	  (Promega,	  USA;	  12.5	  μg/ml	  in	  40	  mM	  ABC	  with	  
10%	  ACN,	  pH	  8.0)	  overnight	  at	  40°C	  (Soriano	  et	  al.,	  2006)	  and	  extracted	  twice	  with	  a	  mixture	  of	  50%	  ACN–
5%	  formic	  acid	  (FA).	  Extracts	  were	  dried	  using	  a	  vacuum	  centrifuge	  Concentrator	  plus	  (Eppendorf).	  	  
For	  MS	  and	  MS/MS	  MALDI	   analysis,	   peptides	  were	   redissolved	   in	   4	  µl	   of	   alpha-­‐CHCA	   (2,5	  mg/ml	   in	   70%	  
ACN-­‐0.1%	  TFA).	  1.5	  µl	  of	  each	  sample	  was	  spotted	  directly	  onto	  a	  dry	  MALDI	  plate	  (ABSciex,	  Foster	  City,	  CA,	  
USA).	  Peptides	  on	  MALDI	  plate	  were	   then	  desalted	  with	  a	   cold	   solution	  of	  10mM	  ammonium	  phosphate	  	  
and	   0.1%	   TFA.	   The	   analysis	   of	   samples	  was	   performed	  using	   a	  MALDI-­‐TOF-­‐TOF	   4800	  mass	   spectrometer	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(ABSciex).	   Spectra	   acquisition	   and	   processing	   was	   performed	   using	   the	   4000	   series	   explorer	   software	  
(ABSciex)	   version	   3.5.28193	   in	   positive	   reflectron	   mode	   at	   fixed	   laser	   fluency	   with	   low	   mass	   gate	   and	  
delayed	  extraction.	  Peptide	  masses	  were	  acquired	  by	  steps	  of	  50	  spectra	  for	  the	  range	  of	  900	  to	  4000Da.	  
MS	  spectra	  were	  summed	  from	  500	  laser	  shots	  from	  an	  Nd-­‐YAG	  laser	  operating	  at	  355	  nm	  and	  200Hz.	  After	  
filtering	  tryptic-­‐,	  keratin-­‐	  and	  matrix-­‐contaminant	  peaks	  up	  to	  15	  parent	  ions	  were	  selected	  for	  subsequent	  
MS/MS	   fragmentation	   according	   to	   mass	   range,	   signal	   intensity,	   signal	   to	   noise	   ratio,	   and	   absence	   of	  
neighboring	  masses	   in	   the	  MS	   spectrum.	  MS/MS	   spectra	  were	  acquired	   in	  1	   kV	  positive	  mode	  and	  1000	  
shots	   were	   summed	   by	   increment	   of	   50.	   Database	   searching	   was	   carried	   out	   using	   Mascot	   2.2	  
(MatrixScience,	  London,	  UK)	  combining	  MS	  and	  MS/MS	  interrogations	  on	  human	  from	  SwissProt	  databank	  
(20	   321	   sequences,	  March	   2012,	   www.expasy.org).	   Positive	   identification	  was	   based	   on	   a	  Mascot	   score	  
above	  the	  significance	  level	  (i.e.	  <5%).	  The	  reported	  proteins	  were	  always	  those	  with	  the	  highest	  number	  of	  
peptide	  matches.	  Under	  our	  identification	  criteria,	  no	  result	  was	  found	  to	  match	  to	  multiple	  members	  of	  a	  
protein	  family.	  	  
MS	   and	   MS/MS	   ORBITRAP	   analyses	   were	   realized	   using	   an	   Ultimate	   3000	   Rapid	   Separation	   Liquid	  
Chromatographic	   (RSLC)	   system	   (Thermo	   Fisher	   Scientific)	   online	  with	   a	   hybrid	   LTQ-­‐Orbitrap-­‐Velos	  mass	  
spectrometer	  (Thermo	  Fisher	  Scientific).	  	  Briefly,	  peptides	  were	  loaded	  and	  washed	  on	  a	  C18	  reverse	  phase	  
precolumn	  (3	  µm	  particle	  size,	  100	  Å	  pore	  size,	  150	  µm	  i.d.,	  1	  cm	  length).	  The	  loading	  buffer	  contains	  98%	  
H2O,	  2%	  ACN	  and	  0.1%	  TFA.	  Peptides	  were	  then	  separated	  on	  a	  C18	  reverse	  phase	  resin	  (2	  µm	  particle	  size,	  
100	  Å	  pore	  size,	  75	  µm	  i.d.,	  15	  cm	  length)	  with	  a	  4	  min	  “effective	  gradient”	  from	  100%	  A	  (0.1%	  FA	  and	  100%	  
H2O)	  to	  50%	  B	  (80%	  ACN,	  0.085%	  FA	  and	  20%	  H2O).	  
The	  Linear	  Trap	  Quadrupole	  Orbitrap	  mass	  spectrometer	  acquired	  data	  throughout	  the	  elution	  process	  and	  
operated	  in	  a	  data	  dependent	  scheme	  with	  full	  MS	  scans	  acquired	  with	  the	  Orbitrap,	  followed	  by	  up	  to	  20	  
LTQ	  MS/MS	  CID	  spectra	  on	  the	  most	  abundant	  ions	  detected	  in	  the	  MS	  scan.	  Mass	  spectrometer	  settings	  
were:	  full	  MS	  (AGC:	  1*106,	  resolution:	  6*104,	  m/z	  range	  400-­‐2000,	  maximum	  ion	  injection	  time:	  500	  ms);	  
MS/MS	  (AGC:	  5*103,	  maximum	  injection	  time:	  50	  ms,	  minimum	  signal	  threshold:	  500,	  isolation	  width:	  2Da,	  
dynamic	  exclusion	  time	  setting:	  15	  s).	  The	  fragmentation	  was	  permitted	  of	  precursor	  with	  a	  charge	  state	  of	  
2,	  3,	  4	  and	  up.	  For	  database	  searching,	  all	   the	  search	  parameters	  were	  the	  same	  as	  MALDI	  search	  except	  
the	  precursor	  mass	  tolerance	  which	  was	  set	  to	  5	  ppm	  and	  the	  fragment	  mass	  tolerance	  to	  0.45	  Da.	  
Immunoblot	  analysis	  
Some	   spot	   showing	   expression	   changes	   with	   proteomic	   analysis,	   were	   tested	   by	   comparative	  
immunoblotting	   analysis	   as	   previously	   described	   (Brocca	   et	   al.,	   2012).	   About	   20	   µg	   of	   muscle	   samples,	  
prepared	   and	   used	   for	   2D	   electrophoresis,	   were	   loaded	   on	   Any	   kD	   precast	   polyacrylamide	   gel	   (Biorad	  
product).	   The	   proteins	   were	   electrotransferred	   to	   nitrocellulose	   membranes	   at	   100V	   for	   2h	   and	   the	  
Western	   blot	   analysis	   was	   performed.	   Nitrocellulose	  membranes	   were	   blocked	   in	   5%	  milk	   in	   TBST	   (Tris	  
0.02M,	   NaCl	   0.05	  M	   pH	   7.4-­‐7.6,	   0.1%	   Tween20)	   for	   1h	   and	   then	   incubated	   in	   primary	   antibody	   at	   4°C	  
overnight.	   The	   membranes	   were	   probed	   with	   antibody	   specific	   to	   Lactate	   dehydrogenase	   (rabbit-­‐anti	  
LDHA,	  Abcam),	  Aldolase	  A	  (mouse-­‐anti	  aldolase	  A,	  Abcam),	  Ubiquinol-­‐cytochrome	  c	  reductase	  (mouse-­‐anti	  
UQCRC1,	  Abcam),	  Superoxide	  Dismutase	  1	  (rabbit-­‐anti	  SOD1,	  Abcam),	  Peroxiredoxin	  3	  (mouse-­‐anti	  PRDX3,	  
Abcam),	   α-­‐β	   crystallin	   (rabbit-­‐anti	   α-­‐β	   crystallin,	   Abcam).	   After	   several	   rinses	   in	   TTBS	   (0.1%	   Tween-­‐20	   in	  
TBS),	  the	  membranes	  were	  incubated	  in	  HRP-­‐conjugated	  secondary	  antibody,	  rabbit-­‐anti-­‐mouse	  (Dako)	  or	  
goat-­‐anti-­‐rabbit	   (Cell	   Signalling)	   for	   1h	   at	   room	   temperature.	   The	   protein	   bands	   were	   visualized	   by	   an	  
enhanced	  chemiluminescence	  method	  (ECL	  Advance,	  GE	  Healthcare	  product).	  The	  content	  of	  single	  protein	  
investigated	  was	  assessed	  by	  determining	  the	  brightness-­‐area	  product	  (BAP)	  of	  the	  protein	  bands.	  
Carbonylated	  proteins	  
Carbonylated	   proteins	   were	   analysed	   based	   on	   the	   method	   previously	   reported	   (Brocca	   et	   al.,	   2010).	  
Frozen	   samples	   from	   each	   subject	   group	   were	   suspended	   in	   a	   lysis	   antioxidant	   buffer	   (50	   mM	   Tris-­‐HCl	  
pH7.6,	  250	  mM	  NaCl,	  5	  mM	  EDTA	  protease	  inhibitor	  cocktail	  and	  phosphatase	  inhibitor	  cocktail),	  left	  on	  ice	  
for	  20	  minutes	  and	  finally	  centrifuged	  at	  18000	  g	  for	  20	  min	  at	  4°C.	  Protein	  concentration	  was	  determined	  
using	  the	  RC	  DCTM	  protein	  assay	  kit	  (Biorad	  product).	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The	  protein	  carbonylation	   level	  was	  detected	  using	  the	  OxyBlotTM	  Kit	   (Millipore).	  Carbonyl	  groups	   in	  the	  
protein	   side	   chains	   were	   derivatized	   to	   2,4-­‐dinitrophenylhydrazone	   (DNP)	   by	   reaction	   with	   2,4-­‐
dinitrophenylhydrazine	   (DNPH).	   10	   μg	   of	   proteins	   for	   each	   muscle	   sample	   were	   denatured	   with	   SDS	  
solution	  at	  a	  final	  concentration	  of	  6%.	  The	  DNPH	  solution	  was	  added	  to	  obtain	  the	  derivation;	  the	  reaction	  
was	  stopped	  after	  15	  min	  of	   incubation	  at	  room	  temperature.	  The	  DNP-­‐derivatized	  protein	  samples	  were	  
separated	  by	  polyacrylamide	  gel	  electrophoresis	  (Anykd	  Biorad	  gels)	  followed	  by	  Western	  blotting.	  Proteins	  
were	  transferred	  to	  nitrocellulose	  membranes	  at	  100V	  for	  2h,	  stained	  with	  Ponceau	  Red	  (Sigma)	  and	  then	  
scanned.	   The	  membranes	  were	  blocked	   in	   3%	  bovine	   serum	  albumin	   (BSA)	   for	   1	   h,	   then	   incubated	  with	  
rabbit	   anti-­‐DNP	   antibody	   for	   1h	   at	   room	   temperature	   and	   subsequently	   with	   a	   horseradish	   peroxidase-­‐
antibody	  conjugate	   (goat	  anti-­‐rabbit	   IgG).	  The	  membranes	  were	   treated	  with	  chemiluminescent	   reagents	  
(ECL	  advance	  as	  describe	  previously)	  and	  the	  positive	  bands	  emitting	  light	  were	  detected	  by	  short	  exposure	  
to	  photographic	  films.	  
The	  oxidative	  status	  was	  analysed	  quantitatively	  by	  comparison	  of	  the	  signal	  intensity	  of	  immune-­‐positive	  
proteins	  normalized	  on	  total	  proteins	  amount	  loaded	  on	  gels	  (ponceau	  staining	  signal).	  
	  
Statistical	  analysis	  
Data	  are	  expressed	  as	  the	  mean	  ±	  SEM.	  	  In	  Proteome	  and	  phosphoproteome	  analysis	  the	  data	  are	  
expressed	  as	  ratio	  between	  the	  average	  volume	  of	  a	  given	  protein	  in	  EL	  group	  and	  the	  average	  volume	  in	  
YO	  group.	  Significant	  differences	  between	  EL	  and	  YO	  was	  assessed	  by	  independent	  samples	  Student’s	  t-­‐
test.	  A	  P	  <	  0.05	  was	  considered	  statistically	  significant.	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Results	  
In	  vivo	  analyses	  of	  quadriceps	  mass	  and	  function	  
Fig.	  1	  shows	  the	  mean	  values	  of	  quadriceps	  volume	  determined	  by	  MRI,	  maximum	  voluntary	  torque	  (MVC),	  
patellar	   tendon	   force	   (Ft),	   and	   patellar	   tendon	   force	   normalized	   for	   quadriceps	   volume	   (Ft/Qvol)	   of	   the	  
populations	  of	  young	  and	  elderly	  subjects.	   It	  can	  be	  observed	  that	  quadriceps	  volume,	  MVC,	  and	  Ft	  were	  
significantly	   lower	   in	   elderly	   compared	   to	   young	   subjects.	   Differences	  were	   31%	   for	   quadriceps	   volume,	  
45%	  for	  MVC,	  41%	  for	  FT.	  Ft/Qvol	  was	  16%	  lower	  in	  elderly	  than	  in	  young	  subjects,	  but	  the	  difference	  did	  
not	  reach	  statistical	  significance.	  Ft/Qvol	  can	  be	  considered	  analogous	  to	  in	  vivo	  specific	  force.	  	  
Structure	  and	  function	  of	  individual	  muscle	  fibres	  
For	  each	  of	  the	  10	  elderly	  subjects	  (EL)	  and	  of	  the	  10	  young	  subjects	  (YO),	  at	  least	  10	  single	  muscle	  fibres	  
were	   dissected	   from	   vastus	   lateralis	  muscle	   biopsies.	   The	   analysis	   of	   cross	   sectional	   area	   (CSA),	   specific	  
force	  (P0/CSA)	  and	  unloaded	  shortening	  velocity	  (V0)	  were	  performed	  on	  120	  fibres	  of	  both	  YO	  and	  EL.	  The	  
data	  reported	  focus	  on	  the	  pure	  type	  1	  (YO	  n=37;	  EL	  37)	  and	  type	  2A	  (YO	  n=30;	  El=45)	  fibres.	  Hybrid	  fibres,	  
either	   type	   1-­‐2A	   or	   2AX,	   were	   not	   considered	   as	   their	   functional	   properties	   could	   be	   affected	   by	   the	  
concomitant	  presence	  of	  more	   than	  one	  MHC	   isoform.	  Few	   fibres	   (2%)	  were	  pure	   type	  2X	  and	  were	  not	  
sufficient	  to	  enable	  a	  reliable	  comparison.	  
Fig	   2	   shows	   significantly	   lower	  mean	   values	   of	   CSA,	   Po/CSA	   and	   Vo	   of	   type	   1	   and	   type	   2A	   fibres	   in	   EL	  
subjects	  compared	  to	  the	  YO	  subjects.	  CSA	  was	  16%	  lower	  in	  type	  1	  fibres	  and	  15%	  lower	  in	  type	  2A	  fibres	  
in	  elderly	  subjects	  than	  in	  the	  corresponding	  fibre	  types	  from	  YO	  (Fig.	  2A).	  P0/CSA	  was	  10%	  lower	  in	  type	  1	  
fibres	  and	  26%	  lower	  in	  type	  2A	  fibres	  (Fig.	  2B)	  and	  Vo	  was	  25%	  lower	  in	  type	  1	  fibres	  and	  23%	  in	  type	  2A	  
fibres	  of	  EL	  than	  in	  corresponding	  fibre	  types	  of	  YO	  (Fig.	  2C).	  
Myosin	   concentration	   was	   determined	   in	   all	   individual	   muscle	   fibres	   for	   which	   CSA,	   P0/CSA	   and	   V0	   are	  
reported.	   The	   trend	   towards	   lower	  myosin	   concentration	   (10%)	   in	   EL	   subjects	   compared	   to	   YO	   did	   not	  
reach	   statistical	   significance	   (fig.	  3A).	   The	   ratio	  between	  myosin	  and	  actin	   content	   (M/A),	  determined	  by	  
densitometry	  of	   the	   two	  proteins	  band,	   in	  a	  one	  dimensional	  SDS-­‐PAGE	  gel,	  did	  not	   show	  any	  difference	  
between	  EL	  and	  YO	  (fig.	  3B).	  
Analysis	   of	   MHC	   isoform	   composition	   in	   bulk	   muscle	   samples	   showed	   significantly	   higher	   MHC-­‐1	   and	  
significantly	   lower	  MHC-­‐2A	  and	  MHC-­‐2X	   isoforms	  relative	  content	   in	  EL	  compared	  to	  the	  YO	  (Fig.	  3C).	  No	  
significant	  differences	  were	  found	  in	  MLC	  isoform	  distribution	  (Fig.	  3D).	  	  
Proteomic	  analysis	  
Proteomic	  maps	  of	  vastus	  lateralis	  muscle	  of	  YO	  and	  EL	  were	  obtained	  using	  2D	  gel	  electrophoresis.	  In	  each	  
2D-­‐gel	   more	   than	   800	   protein	   spots	   were	   detected	   and	   analysed	   for	   differential	   expression	   (Fig.	   4B).	  
Protein	  spots	  showing	  significantly	  different	  expression	  were	  subsequently	  identified	  by	  MALDI-­‐Tof	  (Table	  
1)	  and	  grouped	  based	  on	  their	   functional	   role	   in	   the	   following	  categories:	  myofibrillar	  proteins,	  glycolytic	  
enzymes,	   oxidative	   enzymes,	   antioxidant	   defence	   systems	   and	   other	   proteins.	   Figure	   4A	   shows	   the	  
histogram	  representing	  the	  volume	  ratios	  of	  differentially	  expressed	  proteins	  in	  EL	  subjects	  compared	  to	  YO	  
subjects.	  Bars	  pointing	  to	  the	  right	  (positive	  numbers	  on	  the	  x	  axis)	  indicate	  upregulation	  of	  a	  protein	  in	  EL,	  
whereas	  bars	  pointing	  to	  the	  left	  (negative	  numbers	  on	  the	  x	  axis)	  indicate	  downregulation.	  
Among	  myofibrillar	  proteins,	  two	  spots	  identified	  as	  actin,	  one	  spot	  as	  tropomyosin,	  two	  spots	  as	  troponin	  
T	   fast	   were	   downregulated,	   whereas	   one	   spot	   identified	   as	  MLC1	   slow,	   one	   spot	   as	   actin,	   one	   spot	   as	  
troponin	   T	   fast	   and	   one	   spot	   of	   actin-­‐α-­‐cardiac	   were	   upregulated.	   Since	   no	   alterations	   were	   found	   in	  
myosin/actin	   ratio	   and	   in	   2D	   gel	   actin	   is	   resolved	   in	   several	   spots,	   the	   actin	   content	   was	   additionally	  
investigated	  by	  a	  immunoblotting.	  This	  analysis	  showed	  no	  changes	  in	  actin	  levels	  in	  EL	  compared	  with	  the	  
YO	  group	  (fig.	  5A).	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Several	  expression	  changes	  in	  metabolic	  enzymes	  were	  identified.	  In	  EL	  subjects	  a	  general	  up-­‐regulation	  in	  
glycolytic	   enzymes	   (except	   for	   Lactate	   dehydrogenase	   LDHA)	   and	   in	   oxidative	   enzymes	  was	   observed.	   In	  
particular,	  we	   found	  an	  up-­‐regulation	  of	   pyruvate	   kinase	  3	   isoform	  2,	  Ubiquinol-­‐cytochrome	   c	   reductase	  
(UQCRC1),	   cytochrome	   b-­‐c1,	   cytochrome	   c	   oxidase,	   dihidrolipoyl	   dehydrogenase	   and	   of	   four	   spots	  
identified	  as	  aldolase	  A.	   	   In	  order	   to	  confirm	   the	  variations	  observed,	  we	   tested	   the	  expression	  of	   LDHA,	  
Aldolase	  A	  and	  UQCRC1	  by	  comparative	  immunoblotting.	  The	  results	  confirmed	  proteomic	  analysis	  (fig.	  5C).	  
Proteomic	  analysis	  showed	  the	  greatest	  number	  of	  spot	  alterations	  in	  protein	  belonging	  to	  the	  antioxidant	  
defence	  systems.	  Higher	  expression	  of	  Cu/Zn	  Superoxide	  dismutase	  (SOD1),	  carbonic	  anhydrase-­‐3	  (CAH	  III),	  
heat	   shock	   protein	   B6	   (HspB6),	   Peroxiredoxin-­‐2,	   3	   and	   6	   (PRDX2,	   PRDX3,	   PRDX6),	   two	   spots	   of	   α-­‐β-­‐
crystallin,	   gluthatione	   S-­‐transferase	   Mu	   2	   and	   gluthatione	   S-­‐transferase	   P	   (GSTP1)	   were	   found	   in	   EL	  
compared	  to	  YO.	  
The	  significant	  up-­‐regulation	  of	  SOD1,	  PRDX3	  and	  α-­‐β-­‐crystallin	  observed	  in	  EL	  subjects	  was	  subsequently	  
confirmed	  by	  immunoblotting	  analysis	  (Fig.	  5D).	  
Several	   proteins,	   which	   could	   not	   be	   ascribed	   to	   a	   specific	   functional	   group,	   went	   through	   significant	  
adaptations	  too.	  Proteasome	  α-­‐sub	  isoform-­‐2	  and	  neuropolypeptide	  h3	  was	  significantly	  up-­‐regulated	  in	  EL	  
subjects,	  whereas	  hemoglobin	  and	  hemoglobin	  sub	  alpha	  were	  down-­‐regulated	  in	  EL	  subjects	  compared	  to	  
YO	  subjects.	  
Phosphoproteomic	  analysis	  
Total	  proteins	  extracted	  from	  Vastus	  lateralis	  of	  each	  subject	  were	  separated	  by	  2-­‐DE	  gel	  and	  subsequently	  
subjected	  to	  phosphoproteomic	  analysis.	  Phosphoproteins	  were	  detected	  by	  Pro-­‐Q	  Diamond	  staining	  and	  
analyzed	   using	   2D	   Image	   Platinum	   software.	   The	   data	   showed	   higher	   phosphorylation	   level	   for	   the	  
following	  protein	  spots:	   two	  spots	   identified	  as	  MLC-­‐2s,	  one	  spot	  as	  actin,	   four	  spots	  as	   troponin	  T	  slow,	  
three	  spots	  as	   troponin	  T	   fast,	  GAPDH,	  Aldolase	  A,	   three	  spots	  as	  phosphoglucomutase	  and	  two	  spots	  as	  
myoglobin	  (Fig.	  6A).	  	  
Interestingly,	   the	   protein	   spots	   which	   showed	   higher	   phosphorylation	   did	   not	   show	   any	   change	   in	  
expression	   level.	   It	   should	   be	   noted	   that	   phosphorylation	   levels	   were	   normalised	   on	   protein	   content	   of	  
each	  spot.	  Therefore,	  the	  higher	  phosphorylation	  levels	  reported	  are	  independent	  from	  protein	  content.	  	  
Since	  variations	  of	  MLC-­‐2s	  phosphorylation	   level	   in	  EL	  subjects	  were	   found	   in	  2D	  gels,	  we	   investigated	   in	  
more	  detail	   the	  degree	  of	  phosphorylation	  of	  MLC	   isoforms	   in	  order	   to	  clarify	   the	  variations	  observed	   in	  
shortening	  velocity	   (V0)	  of	   single	  muscle	   fibres.	  The	  analysis	  was	  carried	  out	   in	  mono-­‐dimensional	  gels.	  A	  
significant	  increase	  was	  found	  for	  MLC-­‐2s	  isoform	  only	  (Fig.	  6C).	  
Oxyblot	  analysis	  
The	   Oxyblot	   analysis	   was	   performed	   in	   all	   samples	   in	   order	   to	   detect	   carbonyl	   groups	   introduced	   into	  
protein	  structure	  by	  oxidation.	  	  We	  determined	  the	  oxidative	  level	  of	  total	  protein	  content	  and	  of	  myosin	  
heavy	  chain	  (MHC)	  isoforms	  separately.	  A	  trend	  towards	  a	  higher	  total	  protein	  oxidative	  level	  in	  EL	  subjects	  
(Fig.	   7A)	   was	   found,	   but	   it	   did	   not	   reach	   statistical	   significance.	   The	   oxidation	   of	   MHC	   isoforms	   was	  
significantly	  higher	   in	   EL	   subjects	   than	   in	   YO	   subjects	   suggesting	  a	  preferential	   involvement	  of	  myosin	   in	  
oxidation	  (Fig.	  7B).	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Discussion	  
The	  goal	  of	  the	  present	  study	  was	  to	  identify	  underlying	  causes	  of	  functional	  impairments	  affecting	  skeletal	  
muscle	   fibres	   of	   older	   people,	   without	   the	   confounding	   impact	   of	   sedentary	   living	   or	   functional	  
impairments.	  	  
The	  population	  of	  elderly	   subjects	   (EL)	  was	   carefully	   selected	  based	  on	   criteria	  which	   included	  physically	  
and	   socially	   active	   men	   and	   excluded	   those	   suffering	   any	   condition	   potentially	   causing	   muscle	   wasting	  
(McPhee	   et	   al.,	   2013a).	   The	   	   values	   for	   the	   physical	   activity	   questionnaire	   (average	   8.5,	   while	   <6	   is	  
sedentary),	  grip	  strength	  (average	  was	  37kg,	  while	  <30kg	  indicates	  weakness)	  and	  walking	  speed	  (average	  
was	   1.64	   m/s,	   while	   <0.8	   m/s	   indicates	   slowness(Cruz-­‐Jentoft	   et	   al.,	   2010)	   for	   the	   older	   men	   clearly	  
demonstrate	   good	   physical	   function.	   The	   upregulation	   of	   almost	   all	   the	   differentially	   expressed	   proteins	  
shown	  by	  2D	  proteomic	  maps	  (Fig.	  4),	  the	  unchanged	  myosin	  and	  actin	  content	  suggested	  by	  single	  muscle	  
fibres	   analysis	   (Fig.	   3A-­‐B),	   and	   the	   higher	   relative	   content	   in	   MHC-­‐1	   (slow	   isoform)	   and	   lower	   relative	  
content	   of	   MHC-­‐2A	   and	   2X	   (fast	   isoforms)	   (Fig.	   3C)	   in	   whole	   muscle	   samples	   from	   EL	   compared	   to	   YO	  
indicate	   that	   disuse	   was	   not	   a	   relevant	   phenomenon	   in	   the	   EL	   population	   studied.	   In	   disuse,	   in	   fact,	  
downregulation	  of	  proteins	  dominates	  proteomic	  maps	  (Brocca	  et	  al.,	  2012;	  Brocca	  et	  al.,	  2015).	  Moreover,	  
lower	  myosin	  concentration	  in	  single	  fibres	  (Borina	  et	  al.,	  2010;	  Brocca	  et	  al.,	  2015)	  and	  slow	  to	  fast	  shift	  in	  
MHC	  isoforms	  (di	  Prampero	  &	  Narici,	  2003;	  Brocca	  et	  al.,	  2012)	  are	  observed.	  The	  results	  obtained	  from	  the	  
older	   participants	   can,	   therefore,	   be	   considered	   as	   indicative	   of	   the	   ageing	   process,	   rather	   than	   being	  
secondary	  to	  chronic	  diseases	  and	  lifestyle	  factors.	  
We	  will	   first	  discuss	  adaptations	   in	  proteins	  content,	   i.e.the	  quantitative	  adaptations	  of	   the	  older	  muscle	  
proteome,	  and	  then	  the	  post-­‐translation	  modifications	  of	  proteins	  ,	  i.e.indicating	  qualitative	  adaptations	  of	  
the	   muscle	   proteome.	   Finally,	   we	   will	   consider	   the	   potential	   impact	   of	   quantitative	   and	   qualitative	  
adaptations	   of	   the	   muscle	   proteome	   on	   single	   muscle	   fibres	   specific	   force	   and	   unloaded	   shortening	  
velocity.	  
Adaptations	  in	  protein	  content	  
Myosin	  heavy	  chain	  and	  myofibrillar	  proteins	  
No	  significant	  differences	   in	  myosin	  content	   in	  single	  fibres	  was	  observed	  (Fig.	  3A).	  The	   latter	  result	  does	  
not	  appear	  consistent	  with	  the	  lower	  myosin	  content	  we	  previously	  reported	  in	  muscle	  fibres	  from	  elderly	  
subjects	  (D'Antona	  et	  al.,	  2003).	  However,	   in	  the	  earlier	  work,	  elderly	  subjects	  were	  sedentary	  and	  disuse	  
could	   have	   contributed	   to	   loss	   of	   myosin,	   in	   agreement	   with	   the	   impact	   of	   disuse	   on	   this	   parameter	  
reported	  in	  recent	  human	  studies	  (Borina	  et	  al.,	  2010;	  Pellegrino	  et	  al.,	  2011a;	  Hvid	  et	  al.,	  2016).	  	  
A	   fast	   to	   slow	   shift	   of	  MHC	   (Fig.	   3C)	  was	   expected	   in	   healthy	   ageing	   based	  on	   the	   extensive	  motor	   unit	  
remodelling	   affecting	   Vastus	   Lateralis	   (Song	   et	   al.,	   2009)	   and	   possible	   preferential	   denervation	   of	   fast	  
motor	  units	  with	  ageing	  (Powers	  et	  al.,	  2012).	  The	  conflicting	  reports	  relating	  to	  MHC	  isoform	  distribution	  
in	  previous	  papers,	  namely	  a	  shift	  toward	  slower	  phenotype,	  or	  toward	  faster	  phenotype,	  or	  no	  change	  in	  
phenotype	  in	  elderly	  subjects	  (D'Antona	  et	  al.,	  2003;	  Gelfi	  et	  al.,	  2006;	  Raue	  et	  al.,	  2007;	  Cohen	  et	  al.,	  2009;	  
Reich	  et	  al.,	  2010;	  Konopka	  et	  al.,	  2011),	   likely	  depend	  on	  the	  confounding	  and	  variable	  impact	  of	  disuse.	  
Disuse	   is	  known	  to	  cause	  a	  slow	  to	  fast	  shift	   in	  MHC	   isoform	  distribution,	  the	  opposite	  of	  what	  would	  be	  
expected	  on	  the	  basis	  of	  a	  preferential	  age	  induced	  denervation	  of	  fast	  motor	  units.	  The	  fast	  to	  slow	  shift	  is	  
not	  supported	  by	  MLCs	  distribution	  	  that	  was	  not	  related	  to	  the	  MHCs	  distribution.	  This	  is	  consistent	  with	  
previous	  evidences	   showing	   the	   coordinated	  expression	  between	  MHC	  and	  MLC	   isoforms	   is	   less	   strict	   in	  
human	  muscles	  than	  in	  rodent	  muscles	  (Larsson	  and	  Moss,	  1993,	  D’Antona	  et	  al	  2002).	  
The	  down-­‐regulation	  of	  tropomyosin,	  Troponin	  T	  fast	  and	  actin	  α	  cardiac	  identified	  with	  proteomic	  analysis	  
is	   in	  agreement	  with	  the	  previous	  data	  reported	  by	  Gelfi	  et	  al.	   (Gelfi	  et	  al.,	  2006).	  These	  adaptations	  can	  
potentially	  affect	  single	  muscle	  fibre	  function,	  as	  outlined	  below.	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Metabolic	  enzymes	  
The	   increase	   in	  oxidative	  enzymes	   in	   the	  old	   is	   in	   agreement	  with	  previous	  data	   (Gelfi	   et	   al.,	   2006).	   It	   is	  
generally	  believed	  that	   impaired	  oxidative	  metabolism	   is	  a	  major	  phenomenon	  of	  ageing	  per	  se	   (Chabi	  et	  
al.,	   2008;	   Porter	   et	   al.,	   2015;	   Cartee	   et	   al.,	   2016).	   However,	   contradictory	   results	   have	   been	   reported	  
showing	  higher	  (Hart	  et	  al.,	  2015)	  or	  unchanged	  (Rasmussen	  et	  al.,	  2003)	  oxidative	  metabolism.	  	  	  
Glycolytic	  enzymes	  showed	  a	  contradictory	  trend.	  The	  effect	  of	  ageing	  on	  LDHA	  expression	  is	  controversial.	  
Some	   reports	   showed	   an	   up-­‐regulation	   (Riley	   et	   al.,	   2002),	   whereas	   others	   found	   a	   down-­‐regulation	  
(Ringholm	  et	  al.,	  2011a)	  of	  this	  protein.	  Interestingly,	  it	  has	  been	  shown	  that	  LDHA	  expression	  decreases	  in	  
a	   wide	   variety	   of	   atrophic	   condition	   or	   catabolic	   states	   (Brocca	   et	   al.,	   2010;	   Ringholm	   et	   al.,	   2011b).	  
Pyruvate	   kinase	   and	   Aldolase	   A	   represent	   two	   glycolytic	   enzymes	   playing	   a	   key	   role	   in	   ATP-­‐generating	  
reactions.	  Their	  up-­‐regulation	  suggest	  a	  higher	  glycolytic	  activity.	  	  
Although	   a	   higher	   enzyme	   content	   is	   generally	   considered	   an	   index	   of	   higher	   activity,	   it	   does	   not	  
unequivocally	   demonstrate	   an	   increase	   in	   reaction	   rate.	   In	   fact,	   to	   some	   extent,	   enzyme	   activity	   and	  
enzyme	  content	  could	  be	  modulated	  independently	  (see	  below).	  Regardless,	  the	  adaptations	  of	  metabolic	  
enzymes	   (Fig.	   4)	   do	   not	   support	   the	   idea	   (Cartee	   et	   al.,	   2016)	   that	   impaired	  metabolism	   is	   a	  major	   and	  
necessary	  consequence	  of	  ageing	  per	  se.	  	  
Antioxidant	  defence	  systems	  
Reactive	   oxygen	   species	   (ROS)	   are	   among	   the	   intracellular	   signals	   constitutively	   controlling	   muscle	  
phenotype	  and	  function	  (Jackson,	  2016).	  It	  is	  generally	  accepted	  that	  reactive	  oxygen	  species	  (ROS)	  play	  a	  
primary	   role	   in	   the	   ageing	   process,	   especially	   in	   those	   tissues	   in	  which	   the	   generation	  of	   free	   radicals	   is	  
more	   pronounced,	   such	   as	   skeletal	   muscle	   (Fulle	   et	   al.,	   2004).	   It	   has	   been	   suggested	   that	   a	   major	  
determinant	   of	   lifespan	   could	   be	   the	   free	   radical-­‐induced	   accumulation	   of	   damage	   to	   cellular	  
macromolecules	  (Harman,	  1956)	  and	  decline	   in	  mitochondria	  (Marzani	  et	  al.,	  2005).	  However,	  the	  role	  of	  
oxidative	   stress	   in	   the	   pathogenesis	   of	   ageing	   has	   been	   recently	   challenged	   and	   a	   debate	   is	   ongoing	  
(Jackson,	  2016).	  	  
Our	   data	   show	   a	   general	   up-­‐regulation	   of	   antioxidant	   defence	   systems	   (Fig.	   4),	   suggesting	   a	   reaction	   to	  
cellular	  stress	  (Sandri,	  2010).	  The	  antioxidant	  defence	  systems	  up-­‐regulated	  in	  elderly	  men	  could	  be	  part	  of	  
compensatory	  mechanisms	  against	   increased	  ROS	  production.	  The	   increased	   level	  of	  oxidation	  of	  myosin	  
(Fig.	  7)	  suggests	  that	  up-­‐regulation	  of	  antioxidant	  defence	  systems	  could	  not	  fully	  prevent	  redox	  imbalance.	  	  
Muscle	  fibre	  atrophy	  and	  protein	  content	  
The	  present	  data	  show	  that	  muscle	  fibre	  atrophy	  occurs	  even	  in	  the	  active	  old,	  similar	  to	  what	  happens	  in	  
sedentary	   ageing	   and	   in	   disuse.	   However,	  muscle	   atrophy	   in	   disuse	   and	   ageing	   is	   qualitatively	   different.	  
Whereas	   in	  disuse,	  downregulation	  of	  proteins	  belonging	  to	  major	   functional	  groups	  occur,	  among	  which	  
are	   the	  myofibrillar	   proteins	   and	  myosin	   (Pellegrino	   et	   al.,	   2011a;	  Brocca	   et	   al.,	   2012),	   in	   healthy	   ageing	  
relatively	   few	  myofibrillar	   proteins	   are	   down-­‐regulated	   (Fig.	   4).	  Most	   functional	   groups	   are	   up-­‐regulated	  
(Fig.	  4).	  The	  latter	  differences	  could	  be	  due	  to	  the	  mechanisms	  responsible	  for	  muscle	  mass	  loss.	  In	  disuse	  
the	   imbalance	   between	   muscle	   protein	   synthesis	   (MPS)	   and	   breakdown	   (MPB),	   which	   ultimately	   cause	  
muscle	   atrophy,	   is	   determined	   by	   both	   a	   decrease	   in	   protein	   synthesis	   and	   an	   increase	   in	   protein	  
degradation	   and	   both	   phenomena	   are	   activated	   quickly	   and	   at	   relatively	   high	   levels	   especially	   in	   some	  
disuse	  models	   (Pellegrino	  et	  al.,	  2011b).	   In	  ageing,	   the	  role	  of	  an	   increase	  MPB	  has	  been	  questioned	  and	  
the	  decrease	   in	  MPS	   is	   likely	  due	   to	  anabolic	   resistance	  which	  would	   cause	   continuous,	  but	   slow	  muscle	  
mass	   loss	   (Atherton	  &	   Smith,	   2012).	   Interestingly,	  whereas	   the	  extent	  of	  muscle	   fibre	   atrophy	   in	   human	  
models	  of	  disuse	  or	  ageing	  with	  disuse	  was	  21-­‐31%	  (Borina	  et	  al.,	  2010),	  22-­‐23%	  (Pellegrino	  et	  al.,	  2011a)	  
and	  26-­‐51%	  (D'Antona	  et	  al.,	  2003),	  here	  we	  report	  a	  lower,	  15-­‐16%	  muscle	  fibre	  atrophy	  (Fig.	  2).	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Post-­‐translational	  modifications	  of	  proteins	  
Phosphorylation	  
Global	  analysis	  of	  protein	  phosphorylation	  suggests	  higher	  phosphorylation	  of	  several	  proteins	   in	  healthy	  
ageing	  (Fig.	  6).	  Protein	  phosphorylation	  leads	  to	  changes	  in	  structural	  properties	  of	  substrates,	  but	  can	  also	  
affect	  their	  protein-­‐protein	  interaction	  network.	  These	  changes	  can	  have	  diverse	  biological	  outcomes,	  such	  
as	   affecting	   protein	   subcellular	   localization	   (e.g.,	   nuclear	   translocation	   or	   cytoplasmic	   retention),	   protein	  
degradation	  and	  stability,	  as	  well	  as	  variations	  in	  intrinsic	  catalytic	  activity	  (Sakuma	  et	  al.,	  2009).	  
Some	   myofibrillar	   proteins	   were	   affected	   by	   phosphorylation	   in	   elderly	   subjects	   (Fig.	   6A,	   B).	   The	  
phosphorylation	  of	  MLC-­‐2s	  isoform	  and	  Troponin	  T	  (TnT),	  that	  can	  be	  phosphorylated	  by	  different	  protein	  
kinases	  both	   in	   the	   isolated	   form	  and	   inside	   the	  whole	   troponin	  complex	   (Romanello	   et	  al.,	   2010),	   could	  
contribute	  to	  the	  adaptations	  observed	  in	  single	  muscle	  fibres	  function	  (Fig.	  2)	  (see	  below).	  
Reversible	   protein	   phosphorylation	   is	   widely	   recognised	   as	   an	   essential	   post-­‐translational	   modification	  
(PTM)	  regulating	  metabolism.	  GAPDH	  catalyses	  the	  sixth	  step	  of	  glycolysis	  and	  thus	  serves	  to	  break	  down	  
glucose	  for	  energy	  and	  carbon	  molecules.	  It	  has	  been	  shown	  that	  the	  activation	  of	  GAPDH	  was	  higher	  when	  
the	  GAPDH	  phosphorylation	  was	  increased	  (Roberts-­‐Wilson	  et	  al.,	  2010).	  Phosphoglucomutase	  (PGM)	  is	  a	  
critical	   regulator	   of	   cellular	   glucose	   utilization.	   It	   catalyses	   the	   conversion	   of	   glucose-­‐1-­‐phosphate	   to	  
glucose-­‐6-­‐phosphate.	   PGM	   phosphorylation	   on	   Ser108	   by	   p21-­‐activated	   kinase	   1	   (Pak1)	   increase	   PGM	  
catalytic	  activity	  leading	  to	  an	  increase	  of	  the	  glycolytic	  pathway	  (Robinson	  et	  al.,	  2006).	  Aldolase	  A,	  found	  
predominantly	   in	   muscle,	   degrades	   fructose	   1,6	   bisphosphate	   and	   is	   involved	   primarily	   in	   the	   catabolic	  
pathway	   for	   glucose	   6-­‐phosphate.	   Aldolase	   has	   a	   phosphorylation	   site	   which	   could	   increase	   its	   activity.	  
Collectively	   the	   latter	   results	  on	  enzyme	  phosphorylation	  and	   the	  proteomic	  data	  on	  enzyme	  content	  do	  
not	   support	   the	   idea	   that	   ageing	   is	   necessarily	   associated	   to	   impaired	   energy	  metabolism	   (Cartee	   et	   al.,	  
2016).	  
Oxidation	  
Whereas	   the	   trend	   toward	   a	   higher	   oxidative	   level	   of	   total	   protein	   content	   did	   not	   reach	   statistical	  
significance,	  MHC	  carbonylation	  was	   significantly	  higher	   in	   the	  older	  men.	  The	   latter	   results	   suggest	   that	  
the	  up-­‐regulation	  of	  antioxidant	  defence	  systems	  (Fig.	  4)	  was	  not	  fully	  successful	   in	  counteracting	  protein	  
oxidation.	   It	   is	   not	   surprising	   that	   myosin	   was	   carbonylated,	   whereas	   total	   proteins	   were	   not.	   Myosin,	  
having	  a	  long	  half-­‐life	  (Smith	  &	  Rennie,	  1996),	  is	  more	  exposed	  to	  post-­‐translational	  modifications.	  Myosin	  
carbonylation	   could	   contribute	   to	   the	   adaptations	   observed	   in	   single	  muscle	   fibres	   function	   (Fig.	   2)	   (see	  
below).	  The	  unchanged	  oxidative	  level	  of	  total	  proteins	  assessed	  by	  oxyblot	  does	  not	  rule	  out	  the	  possibility	  
that	  some	  proteins	  were	  significantly	  oxidized	  and	  could	  affect	  muscle	  fibres	  function.	  Indeed,	  it	  has	  been	  
shown	   that	   the	   impact	   of	   oxidation	   on	   muscle	   proteome	   is	   complex	   (Baraibar	   et	   al.,	   2013).	   The	   issue	  
deserves	  further	  attention.	  	  
Structural	  and	  functional	  deterioration	  of	  muscle	  fibres	  	  
The	  loss	  of	  quadriceps	  mass	  and	  force	  in	  vivo	  (Fig.1)	  and	  the	  significant	  atrophy	  and	  impairment	  of	  specific	  
force	  and	  unloaded	  shortening	  velocity	  of	   individual	  muscle	   single	   fibres	   in	  vitro	   (Fig.2)	   support	   the	  view	  
that	   ageing	   per	   se	   alters	   muscle	   fibre	   structure	   and	   function	   independently	   from	   disuse	   and	   diseases.	  
Indeed,	   the	   results	   are	   consistent	   with	   earlier	   studies	   on	   whole	   muscles	   in	   vivo	   (Aagaard	   et	   al.,	   2010;	  
McPhee	   et	   al.,	   2013a)	   and	   on	   single	   muscle	   fibres	   in	   vitro	   (Larsson	   et	   al.,	   1997;	   Frontera	   et	   al.,	   2000;	  
D'Antona	   et	   al.,	   2003;	   Ochala	   et	   al.,	   2007;	   Yu	   et	   al.,	   2007)	   in	   which	   no	   specific	   attempt	   was	   made	   to	  
differentiate	  between	  effects	  of	  disuse	  and	  ageing.	  The	  present	  results	  confirm	  that	  in	  such	  studies	  at	  least	  
part	  of	  the	  altered	  skeletal	  muscle	  function	  could	  actually	  depend	  on	  ageing	  itself.	  	  
The	  lower	  CSA	  and	  specific	  force	  of	   individual	  muscle	  fibres	  can	  contribute	  to	  the	  lower	  muscle	  mass	  and	  
strength	  observed	   in	  vivo	   (Fig.	  1)	   (Aagaard	  et	  al.,	  2010;	  McPhee	  et	  al.,	  2013a).	  However,	   the	  relationship	  
between	  whole	  muscle	  and	  individual	  muscle	  fibres	  structure	  and	  function	  is	  complex.	  Several	  other	  factors	  
could	   be	   involved	   in	   impairment	   of	   in	   vivo	   function	   among	   which	   increased	   fat	   and	   connective	   tissue	  
	   16	  
content	   (Servais	   et	   al.,	   2007),	   variations	   in	   muscle	   architecture	   and	   tendon	   compliance,	   neuromuscular	  
junction	  integrity	  and	  excitation-­‐contraction	  coupling	  (Narici	  &	  Maffulli,	  2010).	  
The	  loss	  of	  specific	  force	  of	  individual	  muscle	  fibres	  in	  ageing	  can	  be	  due	  to	  lower	  number	  of	  acto-­‐myosin	  
interactions	  due	  to	  loss	  of	  myosin	  or	  to	  lower	  force	  generated	  per	  acto-­‐myosin	  interaction	  due	  to	  altered	  
myosin	  molecule	   function	  or	  acto-­‐myosin	  kinetics.	  Specific	   force	   loss	  of	   individual	  muscle	   fibres	  has	  been	  
accounted	  for	  by	  a	  disproportionate	  loss	  of	  myosin	  content	  compared	  to	  fibre	  CSA	  in	  both	  sedentary	  ageing	  
(D'Antona	   et	  al.,	  2003)	  and	  disuse	   (Borina	   et	  al.,	  2010;	  Pellegrino	   et	  al.,	  2011a).	  Here,	   the	   trend	   towards	  
lower	  myosin	  content	  did	  not	  reach	  statistical	  significance	  suggesting	  that	  lower	  number	  of	  myosin	  heads	  
available	  for	  interaction	  with	  actin	  does	  not	  play	  a	  major	  role	  in	  specific	  force	  loss.	  We	  cannot	  completely	  
rule	  out	   that	  myosin	   content	  might	  have	   some,	  minor	   impact	  on	   specific	   force	   loss,	   due	   to	   the	  not	  high	  
number	  of	  fibres	  per	  subject.	  
Neither	  altered	  myosin	  actin	  ratio	  (Fig.	  3B)	  nor	  altered	  MLC	   isoform	  content	  (Fig.	  3D)	  were	  observed	  and	  
could	  account	  for	  the	  lower	  specific	  force	  of	  muscle	  fibres	  in	  EL.	  	  
Interestingly,	   the	   down-­‐regulation	   of	   tropomyosin	   and	   troponin-­‐t	   fast	   (Fig.	   4)	   content	   could	   alter	   Ca2+	  
sensitivity	  of	  muscle	  fibres	  (Rennie	  &	  Tipton,	  2000)	  and	  decrease	  force	  at	  submaximal	  levels	  of	  activation	  of	  
the	  contractile	  apparatus.	  The	  latter	  phenomenon	  could	  affect	  force	  in	  vivo	  as	  muscles	  are	  not	  maximally	  
activated	   in	   most	   motor	   tasks.	   Lower	   Ca2+	   sensitivity	   cannot	   modulate	   specific	   force	   of	   skinned	  muscle	  
fibres	  in	  vitro	  as	  they	  are	  activated	  by	  direct	  exposure	  to	  solution	  containing	  saturating	  Ca2+	  concentrations.	  
However,	   it	   cannot	   be	   ruled	   out	   that	   lower	   content	   in	   tropomyosin	   and	   troponin	   T	  might	   contribute	   to	  
impair	  specific	  force	  by	  altering	  the	  stoichiometry	  of	  the	  sarcomere	  (Riley	  et	  al.,	  2002).	  
TnT	  phosphorylation	  (Fig.	  6)	  could	  be	  involved	  in	  single	  muscle	  fibres	  functional	  impairment	  in	  EL	  subjects.	  
Phosphorylation	   of	   TnT	   by	   the	   α-­‐isoform	   of	   protein	   kinase	   C	   results	   in	   a	   decrease	   in	   the	   maximal	  
actomyosin	   ATPase	   activity	   and	   a	   decrease	   in	   its	   sensitivity	   to	   Ca2+	   (Romanello	   &	   Sandri,	   2010).	  
Phosphorylation	   of	   TnT	   by	   protein	   kinase	   C	   ζ-­‐isoform	   leads	   to	   a	   slight	   increase	   in	   the	   Ca2+	   sensitivity	   of	  
actomyosin	  ATPase	  and	  does	  not	  influence	  the	  maximal	  ATPase	  activity	  of	  actomyosin	  (Romanello	  &	  Sandri,	  
2010).	  It	   is	  supposed	  that	  these	  effects	  are	  due	  to	  decreased	  affinity	  of	  phosphorylated	  TnT	  for	  the	  actin-­‐
tropomyosin	   complex	   (Rommel	   et	   al.,	   2001)	   or	   to	   phosphorylated	   TnT-­‐induced	   decrease	   in	   the	   rate	   of	  
liberation	  of	  reaction	  products	  from	  the	  active	  site	  of	  myosin	   (Rommel	  et	  al.,	  2001).	  Moreover,	  there	  are	  
evidences	  that	  TnT	  phosphorylation	  affect	  interactions	  of	  the	  thin	  filament	  with	  the	  thick	  filament	  (Sacheck	  
et	  al.,	  2007).	  	  
There	  is	  evidence	  that	  MHC	  oxidation	  alters	  the	  myosin	  molecule	  leading	  to	  a	  decrease	  in	  force	  generation	  
(Powers	   et	   al.,	   2005;	   Powers	   et	   al.,	   2010).	   It	   has	   been	   recently	   suggested	   that	  myosin	   post-­‐translational	  
modifications	   actually	   occur	   in	   ageing	   (Li	   et	   al.,	   2015).	   Mainly	   carbonylation,	   but	   also	   methylation	   and	  
deamidation	  were	  suggested	  to	  alter	  both	  force	  and	  velocity	  of	  isolated	  myosin	  in	  in	  vitro	  motility	  assays	  (Li	  
et	  al.,	  2015).	  Here,	  we	  show	  that	  myosin	  can	  go	  through	  significant	  carbonylation	  in	  healthy	  ageing	  (Fig.	  7)	  
potentially	  contributing	  to	  muscle	  fibres	  specific	  force	  loss.	  	  
The	  significant	  reduction	  of	  maximum	  unloaded	  shortening	  velocity	  	  (V0)	  in	  both	  type	  1	  and	  2A	  fibres	  from	  
EL	  subjects	  (Fig.	  2C)	  is	  consistent	  with	  previous	  studies	  on	  muscle	  fibres	  (Larsson	  et	  al.,	  1997;	  D'Antona	  et	  
al.,	  2003)	  and	  with	  studies	  showing	  lower	  actin	  sliding	  velocity	  on	  myosin	  from	  elderly	  subjects	  in	  in	  vitro	  
motility	   assays	   (Hook	   et	   al.,	   2001;	   D'Antona	   et	   al.,	   2003).	   However,	   contradictory	   results	   showing	   no	  
difference	  in	  unloaded	  shortening	  velocity	  between	  elderly	  and	  young	  male	  and	  female	  subjects	  have	  been	  
reported	  (Trappe	  et	  al.,	  2003).	  It	  has	  been	  argued	  that	  the	  discrepancy	  could	  depend	  on	  the	  heterogeneity	  
among	  the	  population	  of	  subjects	  studied	  due	  to	  different	  exercise	  activity	  (D'Antona	  et	  al.,	  2007).	  Here	  we	  
suggest	   that	   impaired	   unloaded	   shortening	   velocity	   is	   a	   feature	   of	   healthy	   ageing,	   notwithstanding	   the	  
normal	  level	  of	  physical	  activity	  (fig.2C).	  
Alterations	   in	   V0	   of	   muscle	   fibres	   could	   depend	   on	   several	   phenomena:	   variation	   in	   MLC	   isoform	  
composition	  (Bottinelli	  et	  al.,	  1994;	  Bottinelli	  &	  Reggiani,	  2000;	  Bottinelli,	  2001),	  alterations	  in	  the	  myosin	  
molecule	  itself	  (Perkins	  et	  al.,	  1997;	  Yamada	  et	  al.,	  2006;	  Coirault	  et	  al.,	  2007;	  Li	  et	  al.,	  2015),	  variations	  in	  
MLC	  phosphorylation	  (Diffee	  et	  al.,	  1996;	  Olsson	  et	  al.,	  2004;	  Greenberg	  et	  al.,	  2009;	  Maffei	  et	  al.,	  2014).	  In	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this	  study,	  the	  distribution	  of	  MLC	  isoforms	  was	  unchanged	  (Fig.	  3)	  and	  could	  not	  explain	  lower	  Vo.	  Several	  
studies	  have	  suggested	  an	   impact	  of	  MLC2	  phosphorylation	  on	  shortening	  velocity.	  Regulatory	   light	  chain	  
phosphorylation	   causes	   disordering	   of	   the	   myosin	   head	   in	   the	   thick	   filament	   leading	   to	   changes	   in	  
contractility	   and	   in	   the	   rate	   of	   cross-­‐bridge	   attachment	   (Sweeney	   &	   Stull,	   1990;	   Levine	   et	   al.,	   1998;	  
Szczesna	   et	   al.,	   2002).	   In	   particular,	   phosphorylation-­‐induced	   decreased	   velocity	   was	   observed	   in	   single	  
muscle	   fibres	   and	   in	   isolated	   myosin	   in	   in	   vitro	   motility	   assay	   (Diffee	   et	   al.,	   1996;	   Olsson	   et	   al.,	   2004;	  
Greenberg	  et	  al.,	  2009;	  Maffei	  et	  al.,	  2014).	  Here,	  higher	  MLC-­‐2s	  phosphorylation	  level	   in	  elderly	  subjects	  
(Fig.	   6A,	   6C)	   provides	   a	   potential	   explanation	   for	   the	   lower	   Vo.	   Moreover,	   it	   has	   been	   shown	   that	   an	  
increase	   in	   myosin	   oxidation	   can	   determine	   a	   decrease	   in	   shortening	   velocity	   and	   in	   ATPase	   activity	   of	  
myosin	   (Perkins	   et	   al.,	   1997;	   Yamada	   et	   al.,	   2006;	   Coirault	   et	   al.,	   2007).	   The	   higher	   oxidation	   of	   MHC	  
observed	  in	  EL	  subjects	  (Fig.	  7B)	  could	  help	  explain	  V0	  variation.	  
Conclusions	  
The	   single	   muscle	   fibres	   or	   relatively	   active	   and	   healthy	   older	   men	   showed	   evidence	   of	   atrophy	   and	  
impairment	  of	  specific	  force	  and	  unloaded	  shortening	  velocity	  compared	  with	  young	  men.	  	  
Our	   results	   also	   show	   imbalance	   of	   redox	   in	   older	  muscle	   and	  we	   suggest	   activation	   of	   the	   antioxidant	  
defence	  systems	  is	  a	  compensatory	  mechanism.	  
The	  muscle	   proteome	   also	   showed	   qualitative	   changes,	   namely	   post-­‐translational	  modifications,	   such	   as	  
phosphorylation	  of	  several	  proteins	  and	  carbonylation	  of	  myosin.	  Myosin	  carbonylation	  suggests	  that	  up-­‐
regulation	  of	  antioxidant	  defence	  systems	  did	  not	  fully	  prevent	  redox	  imbalance.	  
The	  qualitative	  adaptations	  appeared	  to	  play	  a	  larger	  role	  than	  quantitative	  adaptations	  in	  the	  impairment	  
of	   individual	   muscle	   fibres	   function.	   Myosin	   oxidation,	   rather	   than	   myosin	   content	   could	   significantly	  
contribute	  to	  the	  lower	  force	  and	  velocity	  of	  shortening.	  MLC-­‐2s	  phosphorylation	  can	  contribute	  to	  lower	  
velocity	   of	   shortening.	   TnT	   phosphorylation	   can	   contribute	   to	   lower	   specific	   force,	   although	   we	   cannot	  
exclude	  that	  lower	  tropomyosin	  and	  TnT	  content	  also	  play	  some	  role.	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Table	  1	  
	  
Proteins	   Abbreviations	   Acces	  
number	  
Estimate
d	  pI	  in	  2D	  
gels	  
Estimated	  
MW	   in	   2D	  
gel	  (kDa)	  
SCORE	   Function	  
	   Myofibrillar	  proteins	   	   	   	   	   	   	  
1	   Myosin	  light	  chain	  1	  slow	   MLC1s	   P05976	   5.1	   27	   120	   Essential	  light	  chain	  of	  myosin.Does	  not	  bind	  calcium	  
2	   Actin	   ACTA	   P68133	   5.2	   44	   350	   Skeletal	   actin	   is	   the	   major	  
component	   of	   thin	   filaments.	  
Together	  with	  the	  myosin	  form	  the	  
actomyosin	   myofibrils	   that	   are	  
responsible	   for	   the	   mechanism	   of	  
muscle	  contraction	  
3	   Actin	   ACTA	  	   P68133	   5.1	   43	   385	  
4	   Actin	   ACTA	   P68133	   5.1	   42	   265	  
5	   Tropomyosin	  alpha	  chain	   TPM1	   P09493	   4.8	   37	   240	  
Plays	   a	   central	   role,	   in	   association	  
with	   the	   troponin	   complex,	   in	   the	  
calcium	   dependent	   regulation	   of	  
vertebrate	   striated	   muscle	  
contraction	  
6	   Troponin	  T	  fast	  	   TNNT3	   P45378	   4.9	   39	   423	   Binds	   to	   tropomyosin	   and	   helps	  
position	   it	   on	   actin	   and	   with	   the	  
rest	   of	   the	   troponin	   complex	  
modulates	   contraction	   of	   striated	  
muscle	  
7	   Troponin	  T	  fast	  	   TNNT3	   P45378	   4.9	   39	   505	  
8	   Troponin	  T	  fast	  	   TNNT3	   P45378	   6.7	   39	   481	  
9	   Actin	  α	  cardiac	   ACTC	   P68032	   5.1	   31	   299	  
Actin	   is	   a	   dynamic	   structure	   that	  
can	  adapt	  two	  states	  of	  flexibility.	  It	  
has	   been	   suggested	   a	   key	   role	  
during	  development	  
	   	   	   	   	   	   	   	  
	   Energy	  production	  system	   	   	   	   	   	   	  
	   Glycolytic	  enzymes	   	   	   	   	   	   	  
10	   Lactate	  dehydrogenase	  A	   LDHA	   P00338	   8.1	   34	   597	  
Is	   involved	   in	   the	   first	   step	   of	   the	  
pathway	   that	   synthesizes	   (S)-­‐
lactate	  from	  pyruvate	  
11	   Pyruvate	  kinase	  3	  isoform	  2	   PKM	   P14618	   10	   46	   403	  
catalyzes	   the	   transfer	   of	   a	  
phosphoryl	   group	   from	  
phosphoenolpyruvate	  (PEP)	  to	  ADP,	  
generating	  ATP	  
12	   Fructose-­‐biphosphate	  Aldolase	  A	   ALDOA	   P04075	   9.9	   36	   493	  
Plays	   a	   key	   role	   in	   glycolysis	   and	  
gluconeogenesis	  
13	   Fructose-­‐biphosphate	  Aldolase	  A	   ALDOA	   P04075	   11.1	   36	   467	  
14	   Fructose-­‐biphosphate	  Aldolase	  A	   ALDOA	   P04075	   9.9	   41	   662	  
15	   Fructose-­‐biphosphate	  Aldolase	  A	   ALDOA	   P04075	   8.5	   38	   528	  
	   Oxidative	  enzymes	   	   	   	   	   	   	  
16	   Ubiquinol-­‐cytochrome	   c	  reductase	  core	  I	   UQCRC1	   P31930	   5.1	   44	   913	  
Is	   a	   component	   of	   the	   ubiquinol-­‐
cytochrome	  c	  reductase	  complex;	  it	  
mediate	   the	   formation	   of	   the	  
complex	   between	   cytochromes	   c	  
and	  c1.	  
17	   Cytochrome	   b-­‐c1	   complex	  sub2	   UQCRC2	   P22695	   9.1	   43	   678	  
Is	   a	   component	   of	   the	   ubiquinol-­‐
cytochrome	   c	   reductase	   complex;	  
the	   core	   protein	   2	   is	   required	   for	  
the	  assembly	  of	  the	  complex	  
18	   Cytochrome	   c	   oxidase	   sub	  5A	  mit	   COX5A	   P20674	   4.9	   16	   320	  
This	  is	  the	  heme	  A-­‐containing	  chain	  
of	   cytochrome	   c	   oxidase,	   the	  
terminal	   oxidase	   in	   mitochondrial	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electron	  transport	  
19	   Dihydrolipoyl	  dehydrogenase	  mit	   DLDH	   P09622	   5.8	   47	   526	  
Is	   a	   component	   of	   the	   glycine	  
cleavage	   system	   as	   well	   as	   of	   the	  
alpha-­‐ketoacid	   dehydrogenase	  
complexes	  
	   	   	   	   	   	   	   	  
	   Antioxidant	  defence	  systems	   	   	   	   	   	  
20	   Cu/Zn	  Superoxide	  dismutase	   SOD1	   P00441	   5.1	   20	   320	  
Catalyzes	   the	   dismutation	   of	   the	  
superoxide	   (O2
−)	   radical,	   produced	  
as	   a	   by-­‐product	   of	   oxygen	  
metabolism,	   into	   either	   ordinary	  
molecular	  oxygen	   (O2)	  or	  hydrogen	  
peroxide	  (H2O2)	  
21	   Carbonic	  anhydrase	  III	   CAH3	   P07451	   4.9	   30	   576	  
Catalyze	  the	  reversible	  hydration	  of	  
carbon	  dioxide	  
22	   Heat	  Shock	  Protein	  beta	  6	   HSPB6	   O14558	   5.0	   19	   450	  
work	   downstream	   of	   the	   other	  
antioxidant	   defense	   systems	   by	  
removing	   products	   caused	   by	   the	  
formation	   of	   free	   radicals	   and	   by	  
protecting	   cells	   against	   oxidative	  
stress	  
23	   Peroxiredoxin	  2	   PRDX2	   P32119	   5.1	   24	   360	  
Reduces	   peroxides	   with	   reducing	  
equivalents	   provided	   through	   the	  
thioredoxin	  system	  
24	   Peroxiredoxin	  3	   PRDX3	   P30048	   5.0	   27	   247	  
Protects	   radical-­‐sensitive	   enzymes	  
from	  oxidative	  damage	  by	  a	  radical-­‐
generating	  system	  
25	   Peroxiredoxin	  6	   PRDX6	   P30041	   5.0	   29	   471	  
Can	   reduce	   H2O2	   and	   short	   chain	  
organic,	   fatty	   acid,	   and	  
phospholipid	   hydroperoxides.	   May	  
play	   a	   role	   in	   the	   regulation	   of	  
phospholipid	  turnover	  as	  well	  as	   in	  
protection	  against	  oxidative	  injury	  
26	   α-­‐β-­‐crystallin	   CRYAB	   P02511	   5.3	   23	   213	   Has	   chaperone-­‐like	   activity,	  
preventing	   aggregation	   of	   various	  
proteins	   under	   a	   wide	   range	   of	  
stress	  conditions	  27	   α-­‐β-­‐crystallin	   CRYAB	   P02511	   4.9	   22	   408	  
28	   Glutathione-­‐S-­‐transferase	  Mu	  2	  isoform	  1	   GSTM2	   P28161	   5.0	   28	   902	  
Combines	   of	   reduced	   glutathione	  
to	   a	   wide	   number	   of	   exogenous	  
and	   endogenous	   hydrophobic	  
electrophiles	  
29	   Glutathione	  -­‐S-­‐transferase	  P	   GSTP1	   P09211	   5.1	   25	   500	  
Combines	   of	   reduced	   glutathione	  
to	   a	   wide	   number	   of	   exogenous	  
and	   endogenous	   hydrophobic	  
electrophiles	  
	   	   	   	   	   	   	   	  
	   Other	  proteins	   	   	   	   	   	   	  
30	   Proteasome	  α-­‐sub	  isoform	  2	   PSMA2	   P25787	   5.0	   34	   142	  
Cleaves	  peptides	  with	  Arg,	  Phe,	  Tyr,	  
Leu,	  and	  Glu	  adjacent	  to	  the	  leaving	  
group	  at	  neutral	  or	  slightly	  basic	  pH	  
31	   Hemoglobin	  sub	  beta	   HBB	   P68871	   4.9	   16	   358	  
Involved	   in	   oxygen	   transport	   from	  
the	   lung	   to	   the	   various	   peripheral	  
tissues	  
32	   Hemoglobin	  sub	  alpha	   HBA	   P69905	   9.9	   16	   480	  
Involved	   in	   oxygen	   transport	   from	  
the	   lung	   to	   the	   various	   peripheral	  
tissues	  
33	   Neuropolypeptide	  h3	   PEBP1	   P30086	   8.2	   21	   455	  
Has	   a	   variety	   of	   functions	   in	  
nervous	   tissue	   including	   the	   up-­‐
regulation	   of	   the	   production	   of	  
coline	   acetyltransferase	   in	  
cholinergic	  neurons	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Table	  2	  
	  
Proteins	   Abbreviations	   Acces	  
number	  
Estimate
d	  pI	  in	  2D	  
gels	  
Estimated	  
MW	   in	   2D	  
gel	  (kDa)	  
SCORE	   Phosphorilation	  
sites	  
	   Myofibrillar	  proteins	   	   	   	   	   	   	  
34	   Myosin	  light	  chain	  2	  slow	   MLC2s	   P10916	   4.9	   20	   370	  
11	  
35	   Myosin	  light	  chain	  2	  slow	   MLC2s	   P10916	   4.9	   20	   450	  
36	   Actin	   ACTA	   P68133	   5.4	   44	   455	   36	  
37	   Troponin	  T	  slow	   TNNT1	   P13805	   5.7	   38	   356	  
6	  
38	   Troponin	  T	  slow	   TNNT1	   P13805	   5.8	   38	   410	  
39	   Troponin	  T	  slow	   TNNT1	   P13805	   6	   38	   340	  
40	   Troponin	  T	  slow	   TNNT1	   P13805	   6.1	   38	   385	  
41	   Troponin	  T	  fast	   TNNT3 P45378	   7	   38	   225	  
13	  42	   Troponin	  T	  fast	   TNNT3 P45378 7.1	   38	   540	  
43	   Troponin	  T	  fast	   TNNT3 P45378 7.2	   38	   610	  
44	   Glyceraldehyde	  3-­‐P	  dehydr	   GAPDH	   P04406	   9.8	   38	   505	   46	  
45	   Fructose-­‐biph	  Aldolase	  A	   ALDOA	   P04075	   10	   37	   420	   40	  
46	   Phosphoglucomutase	   PGM1	   P36871	   6.5	   58	   445	  
39	  47	   Phosphoglucomutase	   PGM1	   P36871 6.7	   58	   254	  
48	   Phosphoglucomutase	   PGM1	   P36871 6.9	   58	   290	  
49	   Myoglobin	   MB	   P02144	   7.8	   17	   310	  
14	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SOD1 PRDX3 CRYAB 
YO EL YO EL YO EL 
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MHC	  oxidation YO EL YO EL C 
A B 
C 
34.	  MLC	  2	  slow 
35.	  MLC	  2	  slow 
36.	  Actin 
37.	  Troponin	  T	  slow 
38.	  Troponin	  T	  slow 
39.	  Troponin	  T	  slow 
40.	  Troponin	  T	  slow 
41.	  Troponin	  T	  fast 
42.	  Troponin	  T	  fast 
43.	  Troponin	  T	  fast 
44.	  Glyceraldehyde	  3-­‐P	  dehydr	   


















MLC-­‐1 MLC-­‐2s MLC-­‐2f 


















pI 3 5 10 
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